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INTRODUCTION 
 
Aneurysms of visceral arteries are unusual, although they have been  reported 
with increasing frequency in recent years.  Their prevalence has been estimated at 
0.2%-1%1,2 in the general population. Splenic artery aneurysms (SAAs) are the  most 
common type (60%)3 followed by hepatic(20%)1,3; superior mesenteric (5%)4; celiac 
trunk (4%)5; smaller celiac branches (gastric, pancreaticoduodenal, and 
gastroepiploic) (4%)6,7; and jejunal, ileal, and colic arteries(3%)8 [Fig.1] . 
 
 
 
They are clinically important because of the high complication rate associated 
with their rupture.Aetiological factors include atherosclerosis, trauma, surgery, 
inflammation, infection and congential anomalies. These lesions are traditionally 
treated primarily by surgical means, but with the advent of newer imagining 
modalities, trans-catheter embolization is now emerging as a safe procedure9. A 
gastrointestinal surgeon is likely to encounter aneurysms of splanchnic vessels in one 
of the following situations:(1). Incidental discovery of an aneurysm of a visceral 
artery or vein;(2). A false aneurysm of visceral artery as a consequence of adjacent 
gastrointestinal pathology;(3) .A gastrointestinal complication of an abdominal 
aneurysm.   
Splenic artery aneurysm(SAA) are the most frequent type, accounting for 60% 
of all splanchnic artery aneurysms10.  Although giant aneurysms, defined as greater 
than 2.5 cm in greatest diameter, are rare, they have been reported11.The major risk of 
SAAs and pseudoaneurysms is hemorrhage.  Early literature demonstrated a falsely 
elevated risk for rupture as a result of under detection  of SAAs12. More recent data 
suggest that the risk ranges from 3% to 10% and is higher for giant SAAs.  The 
mortality rate after rupture has been estimated at 10% to25%12,13.  Hemorrhage from 
spenic artery pseudoaneurysms has been reported in an many as 37% of 
patients14.Given the risk for rupture, guidelines recommend resection of symptomatic 
SAAs, asymptomatic aneurysms larger than 2.0 cm, and all pseudoaneurysms, to 
avert rupture15. Pancreatitis with secondary pseudocyst formation is the most common 
cause of pancreatic pseudoaneurysms, although they are known to occur in the 
absence of a pseudocyst.  Pancreatic or peripancreatic bleeding is one of the 
formidable and life-threatening complications of pancreatitis. The standard of care in 
dealing with pseudoaneurysms has been surgical intervention; however, many 
interventional radiologists have reported excellent outcome after angio- embolization. 
Hemobilia (bleeding into the biliary tree) is a rare of condition that may be difficult to 
recognize but it is none the less important to include it in the differential diagnosis of 
gastrointestinal bleeding. 
Hemorrhage into the pancreatic duct (Hemosuccus pancreaticus) causes bloods to 
flow through the duct and papilla into the duodenum. Hemosuccus pancreaticus is a 
rare clinical entity that poses considerable diagnostic and therapeutic challenge and 
should be considered in the differential diagnosis of any patient with obscure upper 
gastrointestinal bleeding16. Hemosuccus pancreaticus most commonly occurs in 
association with chronic pancreatitis and the formation of pseudoaneurysms in 
peripancreatic arteries. 
 
 
 
AIM OF STUDY: 
 
 
 
¾ To analyze the varied clinical presentation of bleeding visceral artery pseudo 
aneurysms and to highlight the need for increased awareness of such a rare 
clinical entity and a potentially lethal complication in patients presenting with 
obscure / overt gastro intestinal bleeding in the background of pancreatitis, 
liver trauma and previous pancreatic / biliary surgery. 
 
¾ To asses the central role of mesenteric angiography in the management of 
pseudo- aneurysmal bleed. 
 
¾ To evaluate the safety, efficacy and clinical outcome of non-surgical and 
surgical treatment options (embolization, ligation, resection) for pseudo 
aneurysmal bleeding from visceral arteries with an intent to draw inferences 
and  to setup management  guide lines/protocol. 
 
REVIEW OF LITERATURE : 
PANCREATIC PSEUDOANUERYSMS : 
Problem : 
 Pancreatic pseudoaneurysms are uncommon vascular complications of 
pancreatitis that has have an uncertain evolution with poor prognosis and are 
frequently accompanied by rupture and bleeding (1.5 to 2.4 %)17. The origin of 
pancreatic duct haemorrhage is pancreatic in 60% to 80% of the cases, usually caused 
by the lytic effect of the pancreatic juice17. This affects the wall of neighbouring 
vessels which may burst into adjacent pancreatic ducts directly or after formation of a 
pseudoaneurysm. A pancreatic pseudocyst often acts as an intermediary link and the 
splenic vein may also be involved. Pancreatitis may  also act through the formation of 
ductal calculi which erode into blood vessel which account for about 30% of the  
cases17. In 20% -40% of the cases, a primary aneurysm or pseudoaneurysm of an 
artery close to the pancreas ruptures into the duct of wirsung, leading to massive 
haemorrhage17. 
Incidence: 
The incidence of acute hemorrhage secondary to a bleeding pseudocyst or 
pseudoaneurysm ranges from 2-8%18 but may be as high as 17%19 and is one of the 
most rapidly fatal complications of pancreatitis, with an associated mortality of 12 – 
37%20 in treated patients to more than 90% in untreated patients21,22. Pseudoaneurysm 
formation in patients with chronic pancreatitis who undergo angiography may have an 
incidence as great as 10%20,22. Some of the factors associated with pancreatic 
pseudoaneurysms include the following: 
a) Severity and duration of pancreatitis 
b) Presence of pseudocyst and associated splenic vein  thrombosis and 
endoscopically visualized varices. 
The splenic artery is the  most commonly affected artery (30%-50%)23 because 
of its proximity to the pancreas, followed  by the gastroduodenal artery (10-15%)24 
and the inferior and superior pancreaticoduodenal arteries(10%)25,26.Other blood 
vessels mentioned in the literature include the superior mesenteric artery27,28, hepatic 
artery29, left gastric artery30, gastroepiploic artery31 dorsal pancreatic artery32, and 
middle colic artery8. The overall incidence of gastrointestinal bleeding secondary to 
acute pancreatitis are reported to occur in 1.5-2.5%18,34 of patients, 7-14% in patients 
of chronic pancreatitis and in 6-31% of patients with pancreatic pseudocyst34, but the 
mortality rate in acute pancreatitis is high 40-80%18,34. The mortality accompanying 
bleeding pseudoaneurysms and pseudocyst in chronic pancreatitis is reported to be 
between 12% and 40%18 and thus is considerably lower than that associated with 
hemorrhage from acute pancreatitis, where sepsis and multiple organ failure are often 
also present. 
Etiology: 
The etiologic requisites of the dysplastic  and aneurysmal  changes 
characteristic of pancreatic pseudoaneurysm formation include the following: Acinar 
cell necrosis and or ductal disruption with peripancreatic accumulations of exudative 
fluid containing activated protelytic enzymes which autodigest and weaken the 
arterial wall and lead to pseudoaneurysm formation18,33. Severe inflammation of an 
infected pseudocyst leading to the same sequelae. Moderate-to-severe pancreatitis 
with or without pseudocyst/abscess is the major etiologic factor for pseudoaneurysm 
formation. Pseudoaneurysm formation may occur after biliopancreatic resection for 
cancer. Patients who have an anastomotic leak and develop intra-abdominal abscess 
may subsequently be prone to delayed arterial hemorrhage. Focal sepsis erodes 
through vessels and causes pseudoaneurysm formation and delayed rupture and 
bleeding. Pancreatic transplantation is an occasionally reported third cause of 
pancreatic pseudoaneurysm formation18. 
 
Pathophysiology: 
Pseudoaneurysms form when enzyme-rich peripancreatic fluid often within a 
pseudocyst, leads to enzymatic auto digestion by pancreatic enzymes (trypsin, 
elastases, collagenases) and weakening of the walls of adjacent arteries. The 
histologic changes in the affected vessels include splitting of internal elastic lamina, 
inflammatory thrombosis of nutritive vasavasorum in the arterial wall resulting in the 
development of necrotizing arteritis18,33. These arteries then undergo aneurysmal 
dilatation, with the aneurysmal bulge most often contained within the pseudocyst.  
Rupture of the aneurysm into the pseudocyst converts the pseudocyst into a 
pseudoaneurysm (defined as extravascular hematoma communicating with the intra- 
vascular space). In some instances, a pseudocyst can erode into a nearby artery, 
causing the conversion of pseudocyst into a pseudoaneurysm. A pseudocyst   may 
erode the wall of the bowel with bleeding from from the mucosal surface inself. The 
pseudoaneurysm may then rupture into the pancreatic ductal system causing 
hemorrhage into the  bile duct and hemobilia. the pseudoaneurysm may also rupture 
into the free peritoneal cavity or into the gastrointestinal tract18,33. 
 
Clinical Presentation: 
Because pancreatitis is the most common underlying cause of pancreatic 
pseudoaneurysm, most patients are males with alcoholism (80-90%)18,33 who have 
histories of episodic chronic pancreatitis and secondary pseudocyst formation. The 
diagnosis of visceral artery pseudoaneurysm should be considered in any patient with 
a pseudocyst and a significant abdominal bruit18,33. The pseudoaneurysm tends to 
enlarged when subjected to sufficient intracystic pressure and ultimately ruptures into 
the gastrointestinal tract, biliopancreatic ducts, pseudocyst, peritoneal cavity, or 
retroperitoneum18,33. 
Although highly variable, clinical symptoms are very suggestive and include the 
following: 
a) Anemia of unexplained cause.  
b) Recurrent or intermittent hematemesis or hemotochezia in patients who have 
pancreatitis, particularly when due to chronic alcohol  abuse or trauma . 
c) Rapid enlargement of a pseudocyst or a pulsatile abdominal mass, especially 
in the presence of abdominal bruit and hyperamylasemia. 
d) The syndrome known as hemosuccus pancreaticus, characterized by bleeding 
from   the ampulla of Vater, colicky pain, and jaundice18,33. 
Patients with pancreatitis may have the following symptoms: 
I. Persistent or abrupt increase in abdominal pain. The acute onset  of pain 
is thought to be caused by rapid dilatation of the pancreatic duct by 
bleeding, with resultant elevation of intraductal pressure. As the 
intraductal pressure exceeds the pressure of the blood vessel, it leads to 
tamponade of the pseudoaneurysm and  temporary cessation of bleeding 
occurs and the patients conditions stabilizes. The clot is then lysed a 
variable time later and the cycle repeats itself16. This process might recur 
infrequently over months to years or there may be an unrelenting 
deterioration and life threatening haemorrhage.  
II. Decreasing hematocrit values and / or hemodynamic instability and or 
gastrointestinal bleeding with no obvious intraluminal cause. 
The clinical picture may vary widely. The most common form of bleeding is 
probably rupture into a pseudocyst with eventual bleeding through the pancreatic duct 
and, subsequently, the ampulla of Vater if the pseudocyst is connected with the 
pancreatic duct. This “wirsungorrhagia” (ie, hemosuccus pancreaticus)35 manifests as 
intermittent pain caused by sudden filling with blood and resultant distension of the 
pancreatic duct and may sometimes be accompanied by elevated levels of pancreatic 
enzymes. Once the intraductal pressure reaches a certain level, the bleeding stops a 
clot forms.  The clot subsequently lyses at a later stage, leading the cycle to repeat 
itself. On the other hand, if the pseudocyst does not communicate with the duct of 
Wirsung, then blood accumulates in the pseudocyst, leading to sudden enlargement 
and causing abdominal pain and a drop in the hematocrit value18,33. 
 
Diagnostic evaluations: 
Upper gastrointestinal endoscopy should be the initial investigation in order to 
rule out the more common non-pancreatic causes of gastrointestinal bleed particularly 
in alcoholic patients35. The CT finding of contrast enhancement within or adjacent to a 
non-enhancing pseudocyst is highly suspicious of pseudoaneurysm32,36.  The finding of 
increased attenuation within a fluid collection on a non-enhanced scan is also 
suspicious, indicating recent hemorrhage into pseudocyst20,36. Intravenous bolus 
injection of contrast medium during scanning defines a rapidly enhancing mass within 
a non-enhancing pseudocyst36.  The pattern represents free-flowing blood surrounded 
by low-attenuation thrombus and is demonstrated in 80% of such patients20,36 ..  
 Computed tomography may also demonstrate less specific findings, such as 
intraperitoneal or extra-peritoneal blood or splenic hematoma. The use of oral contrast 
should be avoided, so as not to interfere with subsequent visceral arteriography18. 
Intra-abdominal hemorrhage is easily identified by CT imaging as high- attenuation 
(40-50 HU) heterogenous fluid collections that may have fluid-fluid levels and may 
even exhibit  evidence of extravascular extravasation of contrast material. 
Pseudoaneurysms present as sharply defined, I-contrast filled, round or oval lesions 
along or adjacent to a peripancreatic artery36. Contrast enhanced Dynamic / Helical 
CT is the best non invasive diagnostic modality for pancreatic arterial 
pseudoaneurysm with a reported sensitivity of 80-100%37-38 . 
Ultrasound examination of a patient with a past history of pancreatitis should 
include pulsed or Colour Doppler interrogation of all cystic masses in or adjacent to 
the pancreas so as to distinguish a pseudocyst from a pseudoaneurysm20. 
Ultrasonography has the advantages of being portable and non-invasive, and the 
addition of Color Doppler permits conclusive demonstration of arterial blood flow 
within cystic lesions20,36.  This may provide specific diagnosis and identification of the 
artery involved. 
Angiography is currently the gold standard for diagnosing pancreatic 
pseudoaneurysm32,39 except in situation of   rapid clinical deterioration that mandates 
immediate operative intervention. In hemodynamically stable patients, Contrast 
enhanced Helical /Dynamic CT followed by immediate celiac/ mesenteric 
angiography should be done to confirm the diagnosis18. Angiography defines the 
character-unique or otherwise-of the lesion and allows therapeutic planning. 
Angiography greatly facilitates identification of the location and serves as a 
topographical guide for the pseudoaneurysm, which aids in operative proximal and 
distal control of the bleeding vessel32. Preoperative angiography might constitute an 
opportunity to gain temporary control over the bleeding vessel by performing trans-
catheter embolization, thus providing a time window for the surgeon to operate on a 
high-risk patient under optimal clinical conditions40. In patients with gastrointestinal 
or intraabdominal hemorrhage that is refractory to resuscitative measures, time-
consuming efforts to establish an exact anatomical or etiologic diagnosis are 
detrimental and the only procedure should be immediate laparotomy and surgical 
exploration18. Fortunately, most patients with pancreatic hemorrhage can be stabilized, 
atleast temporarily, thus affording an opportunity for more precise pre operative 
diagnosis and possible potable non-operative control of the bleeding vessel18. In all 
such patients, the most important diagnostic procedure is immediate coeliac / superior 
mesenteric arteriography18.  
Review of the surgical and radiological literature indicates that, among 213 
patients with pancreatic hemorrhage who underwent complete angiographic 
examination, 201 or 94% had accurate identification of the bleeding lesion.  Thus, 
arteriography is extremely sensitive in confirming the diagnosis of pancreatic 
hemorrhage and in identifying the vessel responsible.  It should be the initial and only 
imaging study in patients strongly suspected of having major hemorrhage secondary 
to pancreatitis and its sequelae18. Very small pseudoaneurysms remain a special 
problems because their size is beyond the spatial re solution of noninvasive imaging. 
The incidence of these tiny arterial lesions  are exceedingly low: according to white et 
al41. Very small pseudoaneurysms comprise 20% of all pancreatic pseudoaneurysms, 
with a prevalence of patients with chronic pancreatitis. In these circumstances, 
arteriography remains the only diagnostic tool capable of determining the source of 
the GI bleeding. However, indication for arteriography is usually dictated by the 
recurrence of hemorrhage and clinical symptoms42. 
Non-Surgical therapy: 
Although occasional reports have alluded to the spontaneous thrombosis of 
some pancreatic pseudoaneurysms, the current consensus holds that all these 
malformations should be treated to prevent the complication of bleeding317,32. 
Nonsurgical management consists of trans-catheter arterial embolization with or 
without endoscopic stent placement18,32 Simple pseudoaneurysms (i.e., those unrelated 
to pseudocysts) are effectively treated with embolization, with good results at long 
term follow-up regardless of the location of the pseudoaneuyrsm43 . Angio-
embolization is considered much less invasive than surgery.  The procedure can be 
completed quickly and is comfortable for the patient.  It also allows the performance 
of surgery under optimal conditions.  Recent reports have shown that percutaneous 
angiographic embolization may be the therapy of choice with high technical success 
rates of 67% to 100%39,87, low morbidity rates of 14% to 25% and death rates of 0% to 
14%32,38,42,44.  Most authorities agree that embolization is appropriate when bleeding is 
diffuse or emanating from the pancreatic head, for unsuccessful surgery or during 
postoperative bleeding18.  
Trans-catheter embolization should always be attempted immediately 
following angiographic demonstration of the bleeding vessel of pseudoaneurysm. As 
multiple pseudoaneurysms may be present in 10% of patients, complete visualization 
of the celiac and superior mesenteric arteries and their branches is mandatory18.  
Selective catheterization of the appropriate artery is then undertaken, with the intent 
of occluding it first distal and then proximal to the bleeding site or lesion32,39.  In some 
instances, occlusion of the actual defect in the wall of the artery is made possible by 
the presence of a narrow-necked pseudoaneurysm. In cases of small 
pseudoaneurysms, the entire lumen can be filled with embolization material. Ideally, 
the technique of angiographic embolization is aimed at direct occlusion of the 
pseudoaneurysm by placement of steel micro coils within the neck of the lesion using 
coaxial super selective micro catheters. If the pseudoaneurysm cannot be reached, all 
feeding vessels should be occluded with micro coils32,39,43,45.   A wide variety of 
materials have been to perform trans-catheter embolization, including wire coils, 
detachable balloons, gelatin sponge, autologous blood clot, polyvinyl alcohol 
particles, tissue adhesive, and biological glues18,39,42.  The overall complications rate 
for trans-catheter embolization for pancreatic hemorrhage has been reported to be 
between 3% and 18% with the major risks including pancreatitis, pancreatic necrosis, 
splenic infarction, bowel ischemia, infection and contrast-induced acute renal 
failure18,39,42 .  Review of 125 cases reported in the literature indicated a failure rate of 
embolization of 24% and an overall mortality rate of 10%18.  Failure results from an 
inability to selectively catheterise the bleeding vessel or the misplacement or poor 
placement of embolization material.  In addition to rebleeding, complication of this 
procedure includes rupture of the pseudoaneurysm during embolization, arterial 
perforation by the catheter, intestinal necrosis, and aortic thrombosis42. 
 
Surgical therapy: 
Most patients with acute hemorrhagic pancreatitis respond to resuscitative 
measures with intravenous fluid infusion and transfusion of red blood cells and blood 
components. The very few with exsanguinating hemorrhage refractory to resuscitation 
require expeditious laparotomy and direct operative control of bleeding from a major 
artery18.  The vast majority of such pancreatic have extensive pancreatic necrosis, with 
or without pancreatic abscess or infected necrosis.  The operative approach is 
inevitably difficult. Because of inflammatory adhesions, phlegmonous swelling of the 
pancreas, and tissue hyperemia and friability, all of which obscure the bleeding source 
and distort the vascular anatomy18,19,45  
Successful vascular control may require debridement or necrosectomy of 
pancreatic and peripancreatic tissue, drainage and exploration of abscess cavities, and 
occasionally, removal of other involved organs, such as the stomach, transverse colon, 
or spleen46.  Although ideal, in most instances a clean dissection and accurate 
proximal and distal ligation of the bleeding vessel are technically not possible, 
because of inflammatory swelling.  Therefore, direct suture ligation of the active 
bleeding site frequently must be relied upon.  Partly as a consequence of the surgical 
exploration, bleeding sites are often multiple and complete control is extremely 
difficult to achieve.  If during operation the patient becomes hypotensive, 
hypothermic, coagulopathic, or severely acidotic, packing of the bleeding area should 
be accomplished as quickly as possible, once all obvious arterial bleeding is 
controlled18.  The operation is then terminated with packs left in place.  Such patients 
should be taken to the intensive care unit for volume restoration, rewarming and 
correction of acidosis and coagulopathy and the returned to the operating room in 24 
to 48 hours in the removal of   packs, further exploration and suture control of 
residual bleeding sites, and repacking or wide drainage of the retroperitoneum as 
required.  The overall mortality rate associated with such heroic surgery as the sole 
treatment modality has been nearly 90%18 . 
In 1986, the efficacy of combined angiographic and surgical management of 
massive arterial hemorrhage in patients with acute pancreatitis was documented by 
investigators from the Massachusetts General Hospital18.  Among 10 patients treated 
by the combined approach, complete hemostasis was achieved by embolization in six 
patients and the survival rate for the entire group was 40%.  These results were 
distinctly superior to those previously obtained by surgery alone in these extremely 
high-risk patients18.  In a recent review of 57 cases of massive bleeding in acute 
pancreatitis collected from the literature, the mortality rate was only 25% among 32 
patients treated by embolization techniques18,47.  It appears emergency arteriography 
with trans-catheter embolization offers the best hope for life-saving control of 
exsanguinating hemorrhage complicating acute pancreatitis32,47. 
Emergency exploratory laparotomy is always indicated once the diagnosis of 
bleeding pseudoaneurysm is confirmed arteriographically, or it is entertained in the 
case of hemodynamic instability caused by an exsanguinating hemorrhage that 
obviates the need for angiography.  A major controversy concerns the best approach 
to control the bleeding.  Arterial ligation on both sides of the bleeding sites, pancreatic 
resection, and intracystic / extracystic multiple ligatures are all suggested therapies.  
Some pseudocyst drainage procedures have been frequently performed concomitantly 
with the primary hemostatic surgery18. 
 
Pre operative details: 
The patient’s hemodynamic status and co-morbid medical issues dictate the 
necessity for invasive hemodynamic monitoring. If the diagnosis of a ruptured 
pseudoaneurysm has been seriously entertained and the patient is haemodynamically 
stable, performing a pre operative angiogram has several benefits32,39,47. Identifying the 
bleeding vessels during surgery is difficult because of the friability, necrosis and 
severe inflammation caused by pancreatitis. Also because pre operative angiography 
identifies the bleeding vessel, it might dictate the optimal therapy. Performing arterial 
ligation or pancreaticoduodenectomy on bleeding vessels involving the pancreatic 
head has been demonstrated to carry a high mortality rate18. 
Intra operative details: 
Multiple effective measures to gain rapid control of the actively bleeding 
pseudoaneurysms include manual tamponade, gauze packing, digital compression of 
the bleeding pseudoaneurysm or pseudocyst, and even supra celiac infradiaphragmatic 
cross-clamping of the aorta for brisk bleeding. Institute these measures especially in 
the actively bleeding haemodynamically unstable patient, while aggressive volume 
resuscitation is being undertaken by anaesthesia team18,34. Exposure of the bleeding 
can sometimes be challenging because the surrounding inflammation from 
pancreatitis obscures the visual field. Several adjunctive techniques have been listed 
to gain operative access to the bleeding pseudoaneurysm; these include Prepyloric 
gastrotomy, duodenotomy and major gastrectomy18,34. Once bleeding vessels identified 
the surgeons may perform intracystic ligation without proximal/distal control or 
resection is not recommended because the friable tissues of the posterior pseudocyst 
wall do not hold sutures, and the feeding vessel that lies deep within the substance of 
the pancreas is still patent18,34,68. 
 
Post operative details: 
The occurrence of post resectional hemorrhage is well documented in the 
literature, with a reported incidence of 5-19% and the mortality rate of 6-58%18,34. This 
may be the result of ongoing pancreatitis, continuous damaging of the arteries, 
iatrogenic trauma to the vessels, and/or inadequate control of the bleeding vessels. 
Some surgeons advocate surgical ligation of the bleeding vessel in the nonseptic 
patient and pancreatic resection those with abscess or established fistula35, where as 
interventional radiologist strongly recommend angioembolization of postoperative 
hemorrhage32,39,. 
 
Complications of pseudoaneurysms: 
The frequency of arterial hemorrhage during pancreatitis varies from 5-10%. 
However, when pseudocysts are present, the bleeding rate rises to 15-20% of the 
cases34,45. The most common site of rupture is intracystic, and the incidence of 
spontaneous hemorrhage arising from a pancreatic pseudocyst reportedly ranges from 
1.4-8.4%34.  Other sites of rupture include the bilio-pancreatic duct, peritoneal cavity, 
retroperitoneum, and sometimes direct erosion into the duodenum and other parts of 
the gastrointestinal tract. Hemorrhage is a significant complication that carries a 
mortality rate of 13-40% and is almost always fatal if left untreated18,34. 
 
Outcome and prognosis: 
The mortality rates following surgical treatment for arterial hemorrhage of 
pancreatic origin ranges from 28-56% and 12-64% according to the patient’s clinical 
status, anatomic location of the pseudoaneurysm and site of bleeding, but not related 
to the surgical method32,45,49. Surgical intervention for treatment of pseudoaneurysm in 
the head of pancreas has a 43% mortality rate but only a16% mortality rate in the 
body or tail of the pancreas18,34. Patients treated with supportive measures have more 
than 90% mortality rate18,. The mortality rate with postoperative hemorrhage is nearby 
double (50-60%)18. For pseudoaneurysm in the head of pancreas, the surgical 
approach necessitates a whipple procedure, which likely contributes to the higher 
mortality rate. Embolotherapy has a high initial success rate of 90-100%32,39,43, 
although some reports indicate a recurrence rate of 17-37%50 and an overall mortality 
rate of 16%40. Embolotherapy is the preferred initial therapy for bleeding originating 
from the head of the pancreas39,43.  
 
Future and controversies regarding the operative management of bleeding 
pancreatic pseudocysts and pseudoaneurysms: 
The major controversy surrounding the operative management of the bleeding 
pseudoaneurysm is whether to perform arterial ligation or pancreatic 
resection18,38,47,49,51.  Proximal and distal arterial ligation is often technically difficult to 
accomplish, because of inflammatory changes and anatomical distortion. When 
effected , however, it usually achieves the goal of thrombosis of the bleeding site, 
equivalent to that obtained by proximal and distal trans-catheter embolization. It 
particularly useful in cases of splenic artery hemorrhage but distinctly more difficult 
to accomplish when bleeding is from the head of the pancreas, where the extensive 
collateral circulation exists.  Intracystic suture ligation is a less reliable means of 
achieving complete control and is attended by the higher bleeding rates of 50-75% in 
some reported series18,45,49 . It should be augmented by extracystic arterial ligation 
whenever possible.  For larger bleeding pseudocysts, the addition of some type of 
internal or external drainage is required to reduce the incidence of postoperative 
infection and abscess formation49. Distal pancreatectomy is relatively more easily 
accomplished and has been associated with a lower operative mortality than has 
pancreatoduodenectomy for bleeding from the head of the gland18,47,49. Review of 153 
cases reported in the literature wherein the site and method of hemorrhage control 
were identified reveals the overall operative mortality rate for bleeding from the body 
and tail of the pancreas to be 12% compared 24% for bleeding from the head of the 
gland18. Another major controversy is whether transarterial catheter 
angioembolization should be the definitive approach or if it should always be 
followed by surgical intervention, especially if bleeding is located in the tail or body 
of the pancreas and/or is associated with a pseudocyst. A third controversy is the 
management of postoperative bleeding despite recent adoption of the operative option 
by more health care providers. A recent article describes the clinical success of 
ultrasound guided percutaneous thrombin–collagen injection into the pseudoaneurysm 
for treating splenic artery pseudoaneurysm in the background of chronic pancreatitis. 
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HEMOBILIA :  
Problem:  
 
Hemobilia is a rare condition that is difficult to recognize and there fore a high 
index of clinical suspicion is needed for early diagnosis in patients presenting with 
obscure gastro intestinal bleeding particularly in the setting of liver trauma and 
following biliary tract surgery. Haemobilia occurs when there is a fistula between a 
vessel of the splanchnic circulation and the intrahepatic or extrahepatic biliary 
system53. In 50% cases of hemobilia, bleeding originates from the liver parenchyma, 
whereas the biliary ducts and the gall bladder are the source in approximately 45% of 
the cases.  Hemobilia, due to pancreatic disease is rare54. 
 
Clinical presentation : 
Quinke53,55 described a triad of symptoms and signs with which haemobilia 
usually presents. These are upper abdominal pain, upper gastrointestinal bleeding and 
jaundice. All three may be present in up to 22 % of patients53. The bleeding may be 
rapid onset following liver trauma, or may be delayed by weeks. Occasionally it may 
be recurrent, with a prodrome of epigastric discomfort that is relieved at the onset of 
upper gastrointestinal bleeding. Previous reviews have found that 50 % of bleeding 
into the biliary tree in intrahepatic; the other 50 % is mostly from the extra hepatic 
bile ducts or gallbladder and rarely the pancreas53,56. The bleeding may be so rapid that 
the blood passes directly into the duodenum, appearing as haematemesis or melaena 
following erosion of hepatic artery pseudoaneurysm into the biliary tree53. 
 
Aetiology : 
Trauma is by far the most common cause of hemobilia accounting for 50% of 
the cases54. The most commonly reported causes of haemobilia are iatrogenic trauma 
mostly as a consequence of biliary surgery or accidental liver trauma. Surgical 
exploration of the biliary tree for biliary stones may also cause haemorrhage as the 
intrahepatic ducts are in close proximity to the hepatic arteries53,56. Surgery of the 
hepatobiliary system may lead to haemobilia following injury to a hepatic artery by a 
suture needle, diathermy, clip or clamp. A pseudoaneurysm developing around the 
damaged vessel is the common lesion preceding the onset of haemobilia and the 
presentation may be delayed by many weeks. The incidence of haemobilia following 
major liver injury has been reported to be as high as 3 %53. 
 
Investigation : 
For patients with upper gastrointestinal bleeding, oesophago-
gastroduodenoscopy (OGD) is the first investigation of choice. If blood or clot is seen 
at the papilla of Vater, haemobilia is likely to be the cause of the bleeding. However 
as few as 12 % of these endoscopies may be diagnostic and further investigation may 
be required53,56. Many patients with haemobilia will have CT performed at some point, 
particularly those with blunt abdominal trauma, and further evidence of active or 
recent bleeding into the biliary tree and gallbladder may be identified by pooling of 
contrast medium, intraluminal clots and biliary dilatation57,58. Various risk factors for 
developing haemobilia can also be identified including cavitating lesions and 
pseudoaneurysms53. On Ultrasonography of the liver, immediately following a bleed 
into the biliary tract, with the formation of clot from 24 – 48 hours, a soft tissue mass 
may be seen, filling part of the duct with dilatation of the proximal duct with high 
echogenicity similar to that of the liver. Pseudoaneurysm of the hepatic arteries may 
be noted as well circumscribed anechoic masses; although they are not necessarily 
pulsatile. Doppler ultrasonography may show flow within it differentiating it from 
biloma or cyst59. Angiography is now recognized as the gold standard for confirming 
the site and aetiology of haemobilia65. Angiography can detect a vascular abnormality 
in over 90 % of cases of significant haemobilia as well as it can detect active bleeding 
from arteriobiliary fistula, arterioportal fistula and pseudoaneurysm53,60.  There is a 
role for scintigraphy in the investigation of suspected haemobilia only if other 
investigations have proved normal53. 
 
Management : 
The management of haemobilia is directed at stopping bleeding and relieving 
biliary obstruction. Trans-catheter arterial embolization(TAE) is indicated for those 
cases of major haemobilia requiring blood transfusion, if bleeding is prolonged or 
recurs despite correction of coagulopathy, and in cases of minor haemobilia causing 
anaemia61-63. It is also indicated if CT or ultrasonography indicates vascular injury. 
Surgery is indicated when TAE has failed, for cholecystitis, when there is hepatic and 
biliary sepsis and for failure to drain the biliary tree62. Surgery for bleeding involves 
ligation of the bleeding vessel or excision of the pseudoaneurysm. If haemorrhage 
from collateral vessels continues even after ligation of the common hepatic artery, 
resection of the affected liver segment (partial hepatectomy) may be necessary64.  
 
BLEEDING VISCERAL ARTERY PSEUDOANEURYSMS FOLLOWING 
PANCREATODUODENECTOMY : 
Problem : 
Pancreatic anastomotic leak, extensive surgical dissection during whipple’s 
procedure with an intent to remove all neural and lymphatic tissue around hepatic 
arteries, sometimes results in life threatening complication of arterial hemorrhage 
with a mortality rate of 20 – 50 %66,67. 
Etiopathogenesis:  
There are four predisposing factors for the formation of pseudoaneurysms 
after hepatobiliary pancreatic surgery. The first is leakage of pancreatic juice, 
intestinal juice and/or bile, which erodes the arterial wall by trypsin and elastase18,33. 
The second is localized infection and abscess formation in intra- abdominal space 
after surgery .The third is intraoperative injury of a small artery, especially during 
lymph node dissection. The fourth is a post operative intraabdominal haematoma that 
fails to resorbe may serve as a nidus for infection near a peripancreatic vessel and 
form a pseudoaneurysm69,70-73.  
Pseudoaneurysm can  develop in the gastroduodenal artery or the hepatic 
artery  after hepatobiliary  pancreatic surgery and also in intrahepatic branches of the 
hepatic arteries after  surgery. These pseudoaneurysms present with hemorrhage as a 
late postoperative complication 2-10 weeks after surgery , as shown in the study by 
Rumstadt et al72. Brodsky and Turnbull67 have reported that sentinel bleeding indicates 
local recognition of its significance and prompt response may prevent exsanguination. 
Clinical presentation : 
Majority of patients present with a warning minor sentinel bleed either via: the 
abdominal drains or gastrointestinal tract followed by massive arterial hemorrhage69. 
Diagnostic evaluation : 
Endoscopy is usually employed as the first diagnostic procedure in patients 
with minor sentinel bleed. Angiography is the first-step diagnostic method in patients 
with major arterial hemorrhage after pancreaticoduodenectomy69. Ultrasonography 
findings can be misinterpreted as hematomas where as dynamic CT are diagnostic of 
extrahepatic pseudoaneurysms74. 
Management : 
Percutaneous trans-catheter super selective coil embolization is the initial treatment of 
choice as it can achieve temporary control of massive hemorrhage with a success rate 
of 63-79 %69 and allows hemodynamic stabilization in the majority of cases and 
prevents the need for high risk emergency surgery. Surgery should be reserved for 
patients with uncontrolled intra-abdominal sepsis to avoid a possible recurrent 
bleeding69. During relaparotomy it will be technically difficult to reach the site of 
bleeding pseudoaneurysm because the tissues are edematous, friable and the tissue 
places are difficult to dissect owing to dense adhesions69,72. 
PATIENTS AND METHODS: 
 
  
During the period between January 1998 to August 2005, 16 patients  with 
bleeding visceral artery pseudo aneurysms were recognized and treated at our center 
for gastro intestinal bleed and division of Hepato biliary- pancreatic diseases, 
Department of surgical gastroenterology, Government Stanley Medical College and 
Hospital, Chennai-1. Of the 16 patients, 12 (75.0 %) were males with the median 
(range) age of the group was 40 (18-53) years; 4 (25.0 %) were females with the 
medium (range) age of 34 (12 – 40) years. The male: female ratio being 5.5: 2. Of the 
cohort of 16 patients, one developed pseudo aneurysmal bleeding during the course of 
severe acute alcoholic pancreatitis, 3 as a complication of chronic pancreatitis, 7 as a 
complication of pancreatic pseudocyst, two as a complication of  laparoscopic 
cholecystectomy, two as a complication of blunt liver trauma and one as a 
complication of whipple’s pancreatoduodenectomy. Data were recorded on 
demographic characteristics, co-morbid conditions, mode of clinical presentation, 
etiology, pseudo aneurysm characteristics, investigations, angiographic diagnoses and 
interventions, surgical interventions and final outcome including morbidity and 
mortality. The principal outcome measures were varied modes of clinical 
presentation, results and diagnostic yield of selective celiac / mesenteric angiography, 
efficacy and clinical outcome of therapeutic angiographic embolization and surgical 
interventions including their overall outcome. Demographic data are presented as 
median (range) unless otherwise indicated. Data for statistical comparison are 
presented as median (95 % confidence interval). The study population were outlined 
in tables1-5. 
 
Table -1. PATIENTS TREATED WITH SURGERY AS FIRST LINE DEFINITIVE THERAPY 
WITHOUT PRIOR ANGIOGRAPHY: [ Patients considered unsuitable for angioembolization ] 
(n = 5) 
           
Patient 
No. 
Age 
Yrs 
Sex Disease Status Pseudoaneurysm 
Size 
Vessel Operative procedure 
Case 1 40 M CP 7 cm SA Distal pancreatectomy 
Case 2 42 M CP 8 cm SA Distal pancreatectomy 
Case 3 40 F Blunt liver 
trauma 
5 cm RHA Right hepatectomy 
Case 4 32 F Post Lap. Chole 
RHA – injury 
9 cm RHA Suture repair of bleeding 
vessel 
Case 5 47 M AP 10 cm MCA RHC and external 
drainage 
 
CP – Chronic pancreatitis,  SA – Splenic artery,  RHA – Right hepatic artery, RHC – Right 
hemicolectomy, MCA – Middle colic artery, Lap. chole – Laparoscopic cholecystectomy 
 
Table – 2. PATIENTS TREATED WITH ANGIOGRAPHIC EMBOLIZATION AS FIRST 
LINE DEFINITIVE THERAPY (n=4) 
 
Patient Age 
Yrs 
Sex Disease Status Pseudoaneurysm 
Size 
Vessel Embolic 
material 
outcome 
Case 6 31 M CP 3 cm GDA Microcoils  Successful 
Case 7 36 F Post Lap. 
Chole 
2 cm RHA Tungsten coils Successful 
Case 8 43 M CP 2 cm IPDA Microcoils  Successful 
Case 9 39 F CP 2.5 cm SPDA Microcoils  Successful 
CP – Chronic pancreatitis,  GDA – Gastroduodenal artery, RHA – Right hepatic artery, IPDA – 
Inferior pancreaticoduodanal artery, SPDA – Superior pancreaticoduodenal arcade, Lap. chole – 
Laparoscopic cholecystectomy 
 
 
Table -3.PATIENTS TREATED WITH SURGERY AS SECOND LINE THERAPY FOR 
UNSUCCESSFUL/FAILED ANGIOGRAPHIC EMBOLIZATION : (n = 5) 
 
Patient Age 
Yrs 
Sex Disease Status Pseudoanerysm 
Size 
Vessel Operative procedure 
Case 10 18 M CP 8 cm SA Central pancreatectomy 
Case 11 39 M CP 9 cm SA Intracystic ligation 
Case 12 12 F CP 3 cm SA Distal pancreatectomy 
Case 13 37 M Blunt liver trauma 7.5 cm RHA Right hepatectomy 
Case 16 53 M Post-whipple PD 8 cm HAP Proximal arterial ligation 
CP – Chronic pancreatitis, SA–Splenic artery, RHA – Right hepatic artery, PD – 
Pancreaticoduodenectomy, HAP – Hepatic Artery Proper 
 
Table-4. PATIENTS TREATED WITH SURGERY AS SECOND LINE THERAPY FOR 
REBLEEDING AFTER EMBOLIZATION (n = 1) 
  
CP – Chronic pancreatitis,  GDA – Gastroduodenal artery. 
Patient Age 
Yrs 
Sex Disease 
Status 
Pseudo 
aneurysm 
Size 
Vessel Embolic 
Material 
Outcome of 
Embolization 
Operative 
Procedure 
Case 
14 
53 M CP 7 cm GDA Micro 
Coils 
Rebleeding Intracystic 
ligation 
Table-5. PATIENTS TREATED WITH SURGERY AS SECOND LINE THERAPY FOR 
SEPTIC COMPLICATION AFTER SUCCESSFUL ANGIOGRAPHIC EMBOLIZATION :  
(n = 1) 
 
CP – Chronic pancreatitis,  SA – Splenic artery, PA – Pseudoaneurysm 
 
 
 
STUDY DESIGN: 
 
 
 A collective retrospective survey of a cohort of 16 patients treated in a single 
institution with bleeding as vascular complications of pancreatic inflammatory 
disease, liver trauma and following pancreatic/biliary surgery. 
Inclusion criterion was the diagnosis of a pseudoaneurysm by means of 
Helical Computed Tomography (CT), Conventional angiography, CT angiography, 
Color Doppler Ultrasonography, Endoscopy or intra-operative findings. True 
aneurysms and renal artery pseudoaneurysms were excluded from the study. All 
available hospital medical records, imaging study reports and pathology reports were 
examined. Clinical follow up was complemented by review of the medical records 
and telephone contact with the patient and family or primary care physician.  
 All patients had blood investigations performed which comprises a full 
blood count, renal function tests, blood sugar and serum electrolytes and a liver 
function profile including prothrombin time. All patients had upper 
gastrointestinal (G.I) endoscopy and abdominal ultrasonography. Coeliac / 
mesenteric angiography was performed via femoral artery access using the 
seldinger’s technique. All patients were followed up at two weeks, one month 
and then at 3-month intervals for atleast one year after angiographic 
embolization and surgical intervention. 
Patient Age 
Yrs 
Sex Disease 
Status 
PA 
Size 
Vessel Embolic Material Outcome of 
Embolisation 
Operative 
Procedure 
Case 
15 
51 M CP 8cm SA Autologous 
blood clot + 
Gelfoam  
Infection of 
thrombosed 
PA, No 
Rebleed 
External 
drainage 
 Terms of reference and disease description for purpose of study: 
  
Major pseudoaneurysmal bleeding was defined as hemorrhage comprising 
either gastrointestinal or intra-abdominal bleeds associated with an acute drop of 
haemoglobin concentration by more than 2g/dl requiring transfusion of atleast four 
units of packed red cells within the first 24 hours and / or significant hemodynamic 
deterioration in an otherwise stable patient that could not be attributed to any other 
causes69.  
A pseudoaneurysm was defined as a pulsatile extravascular hematoma that 
communicates with an artery via a disruption of the arterial wall71. Nomenclature for 
description of acute pancreatitis and it’s complications were according to that of the 
current Atlanta consensus conference classification 1992 75 as well as for chronic 
pancreatitis according to those proposed in Marseille 1984 76.  
A positive angiogram was defined as angiographic demonstration of 
extravasation of  contrast and or the identification of a pseudoaneurysm77. Technical 
success of angioembolization was defined as cessation of blood flow in the target 
feeding vessel as demonstrated on post-embolization angiography with complete 
occlusion of the lesion and no recorded rebleed within 48 hours and no recorded 
rebleed within 48 hours78. Clinical success  of angioembolization was defined as the 
cessation of clinical symptoms – melena, hematemesis or hematochezia – after 
embolization with no re-canalization and without any further surgical intervention 
during the post embolization follow-up period78.  
Urgent surgery was undertaken immediately (within 6 hours of angiography), 
usually because of on-going hemorrhage and hemodynamic instability79. Elective 
surgery was defined as an operation undertaken on a hemodynamically stable patient 
on a scheduled basis79.  
Rebleeding was defined as a recurrent episode of bleeding from the 
previously identified site after a period of hemodynamic stability for atleast 12 
hours79. 
Peri operative mortality and morbidity were defined as deaths and 
significant complications occurring during the same hospitalization or within 30 days, 
if patients were discharged earlier48.  
 
Technical details of selective mesenteric angiography: 
 All angiographic procedures were performed by consultant (attending) 
interventional radiologists within 24 hours of onset of bleeding. The transfemoral 
route was selected in all cases in this series. Indications for angiography were either 
evidence of a recent major bleed (as defined above), active bleeding or both. Data are 
recorded on angiographic findings, the use of angiographic hemostatic methods and 
on procedure-related complications. When angiographic embolization was planned it 
was performed as close as possible to the bleeding site using 3-5 mm stainless steel 
fibered coils (Cook Inc, Bloomington, USA), tungsten coils (Peripheral Free Spirales, 
Balt, France)[BALT.SPI-2-60P] or by a combination of autologous blood clot and gel 
foam/gelatin sponge (Spongistan; Johnston and Johnston Medical, Skipton, UK).A 5 
French C2 Cobra [Cook, Bloomington, Ind.] (or) Simon-1 (Cordis) angiographic 
catheter system sufficed in 4 cases; a 3 French super-selective micro catheter (Tracker 
325, Target therapeutics, Boston Scientific, Cork, Ireland) with co-axial delivery 
system was required in two cases because of  unstable position of the catheter. 
Bleeding from the gastroduodenal artery was routinely treated by both proximal and 
distal embolization. All other vessels were embolized proximal to the bleeding point. 
Infusion of vasoactive drugs was not employed in this study, either to elicit bleeding 
or to promote hemostasis. Completion angiography was performed routinely to 
confirm adequate embolization. Once bleeding had stopped and the hemoglobin level 
was maintained, patients were discharged atleast 72 hours after embolization. Post 
procedure Ultrasonography was done after 24 hours to look for splenic infarcts in case 
of splenic artery embolization. Colour Doppler was performed to confirm occlusion of 
the pseudoaneurysm once in every 3 months. CT scan and CT angiography were done 
at the end of 6 months. 
 
RESULTS AND OBSERVATIONS: 
 
 
Age distribution: 
 The most common age group affected in the present series was 30 -39 years 
comprising 53.3 % of study population with median (range) age of 39.5 (12 – 53) 
years. (Fig -2 ) 
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Gender Distribution:  
 
 Majority of study patients were males (75.0 %) with females comprising only 
25.0 %. 
Demographic characteristics of patients based on disease category depicted in Table-
6. 
TABLE.6  DEMOGRAPHIC CHARACTERISTICS OF PATIENTS UNDER STUDY BY 
DISEASE CATEGORY: 
 
 
Disease Status 
 
Hemobilia 
 
CP n = 10 
 
 
 
 
Characteristic  
 
AP  
 With  
pseudocyst 
Without 
pseudocyst 
Post.op after 
lap.chole 
Post - 
traumatic  
after blunt 
 liver  
trauma 
 
 
 
Post. Op after 
pancreato-
duodenectom
y 
 
No. of 
patients 
1 7 3 2 2 1 
M : F One 
male  
6 : 1 All males 3 : 1 One Male 
Median Age 
(range) years 
 
47 
 
39 (12 – 53) 
 
42 (39 – 
51) 
 
36.5 (32 – 40) 
 
51 
AP – Acute pancreatitis, CP – Chronic pancreatitis, Lap.chole- Lapasoscopic Cholecystectomy. 
 
 
CLINICAL PRESENTAION: (Table 7 ) 
 
 Pancreatic pseudocysts 72.7 % (8/11) were the commonest mode of 
presentation of major vascular complications of pancreatitis in the present series. In 
the pancreatitis group, the most frequent type of clinical presentation was upper gastro 
intestinal bleeding (hematemesis and melaena) (9/11 (81.8%)). In the hemobilia 
group, the most frequent type of presentation was upper gastro intestinal bleeding 
which occurred in all patients (100 %) and one patient 1/4 (25.0 %) had triad of upper 
abdominal pain, upper gastro intestinal bleed and jaundice.  
 In the hemobilia group, the earliest presentation was 10 days after surgery 
with median (range) of 52.5 (10 – 90) days. In the post-pancreatoduodenectomy 
bleeding patients, the interval from initial surgery to major pseuoaneursymal bleed 
was 203 days. The interval from bleeding to angiography ranged from 10-24 hours 
with a median of 12 hours. Blood transfused before angiography / surgery in 
postoperative/post-traumatic bleeding group ranged from 4-10 units with a median of 
4.5 units. 
Table 7. VARIED CLINICAL PRESENTATION IN ALL PATIENTS WITH VISCERAL 
ARTERY PSEUDOANEURYSMS – CURRENT SERIES: 
 
 
Presentation 
 
Present Series (n = 16) (%) 
 
Nausea and Vomiting  
Chest pain 
Back pain 
Abdominal / flank pain 
Abdominal pain and upper gastrointestinal bleed 
Abdominal pain and jaundice 
Hematemesis and melaena 
Melaena alone 
Massive gastrointestinal bleed  
Intermittent gastrointestinal bleed 
Hemoptysis and hematochezia 
Worsening anaemia 
Hemobilia 
Abdominal mass 
Abdominal mass with audible bruit 
Bleeding through persistent anterior abdominal wall 
sinus (post-pancreatoduodenectomy) 
 
 
11 (68.75) 
1 (6.25) 
11 (68.75) 
16 (100) 
14 (87.5) 
2 (12.5) 
12 (75.0) 
1 (6.25) 
10(62.5) 
6 (37.5) 
1 (6.25) 
8 (50.0) 
4 (25.0) 
7 (43.75) 
3 (18.75) 
1 (6.25) 
 
 
Laboratory investigations: 
Evidence of cardiovascular compromise/ hemodynamic instability: 
 
 In the present study, the median (range) [95 % CI] serum hemoglobin prior to 
hemorrhage was 11.9 (10.2 – 13.3) g/dl. This fell to 7.1 (5.9 – 8.4) g/dl during the 
bleed. Median transfusion requirement was 7.5 (3 – 10) units of blood. Among 11 
patients, 6 (54.5 %) patients had hemodynamic instability and required blood 
transfusion. In the hemobilia group (n = 4), the median (range) serum hemoglobin 
prior to bleed was 10.7 (9.6 – 11.4) g/dl. This fell to 6.3 (4.6 to 8.4) g/dl during the 
bleed. All patients with hemobilia presented with upper gastro intestinal bleed 
required aggressive resuscitation with crystalloids and blood transfusion. The median 
blood transfusion requirement was 5.5 (4-10) units. 
 
Table. 8 CARDIOVASCULAR COMPROMISED / HEMODYNAMIC STATUS AND BLOOD 
TRANSFUSION REQUIREMENT IN PATIENTS WITH PSEUDOANEURYSMAL BLEED: 
 
PANCREATITIS / PSEUDOCYST GROUP: (n = 11) 
 
Parameter Prior to bleed During the blood (preoperative / pre-
embolization period) 
Serum hemoglobin level (g / dl) 11.9 (10.2 – 
13.3) 
7.1 (5.9 – 8.4) 
Hemodynamic instability  n = 0 n = 6 (54 %) 
Blood transfusion requirement 
median (range) 
n = 0 No. of patients n = 6 (54.5 %) 
No. of units transfused   6.5 (3 – 10) 
 
 
Table.9 HEMOBILIA GROUP: (n = 4) 
 
Parameter Prior to bleed During the bleed (preoperative / pre-
embolization period) 
Serum hemoglobin level (g / dl) 10.7 (9.6 – 11.4) 6.3 (4.6 – 8.4) 
Hemodynamic instability n = 0 n = 4 
Blood transfusion requirement 
medium (range) 
n = 0 No. of patients n = 4 
No. of units transfused 5.5 (4 – 10) 
 
 
LIVER FUNCTION PROFILES: 
 
 In the pancreatitis / pseudocyst group (n = 11), one patient (case 8) jaundice 
and abnormal liver function tests (  bilirubin level,   Alkaline phosphatase level) due 
to a extrinsic compression of bile duct by a large infected pseudocyst at the level of  
 
Table.10.LIVER FUNCTION PROFILES IN HEMOBILIA GROUP (n = 4) 
 
Prothrombin Time Patient no. S. Bilirubin 
(µ mol /l) 
S.AST 
(IU/L) 
S.ALT 
(IU/L) 
SAP (IU) 
Control 
value (secs) 
Test value 
(secs) 
Case 3 
 
Case 4 
 
Case 7 
 
Case 13 
 
26 
 
81 
 
38 
 
42 
22 
 
42 
 
30 
 
26 
20 
 
34 
 
26 
 
22 
190 
 
480 
 
210 
 
360 
16 
 
18 
 
12 
 
12 
20 
 
22 
 
16 
 
16 
S. AST = Serum aspartate aminotransferase, S. ALT = Serum alanine aminotransferase, SAP = Serum alkaline phosphatase  
pancreatic head and portahepatis. In the hemobilia group (n = 4), liver function 
profiles demonstrated a moderate increase in alkaline phosphatase (median 345 (range 
190 – 480) IU; normal upto 150 IU) and mild increase in serum bilirubin level 
(median 59.5 (range 26 to 81) µ mol/l; normal upto 17 µ mol/l) were found to be 
normal levels normal upto 35 IU/L. 
 
DIAGNOSTIC RADIOLOGIC / ENDOSCOPIC INVESTIGATIONS: 
Upper Gastrointestinal (G.I) Endoscopy: 
 Upper GI endoscopy was performed as an initial diagnostic investigation 
patients (n = 15), which identified blood in the second part of duodenum in 3 (26.6 %) 
patients (two in hemosuccus pancreatitis group and one in hemobilia group) and in 12 
(80 %) patients, endoscopic examination was found to be negative/ normal. 
Abdominal Ultrasonography: (USG) 
 Abdominal USG was performed as an initial investigation in all patients (n = 
15), but it dose not prove to be a useful diagnostic investigation to confirm the 
diagnosis. But it is particularly performed in patients presenting with hemobilia 
following blunt abdominal trauma to identify the solid visceral pathology that may 
have indicated the source of bleeding. 
Colour Doppler Utrasonography: 
 Colour Doppler Ultrasonography in combination with CT angiography 
suggested the diagnosis of splenic artery pseudo aneurysm associated with chronic 
pancreatitis in one patient in the present series. 
Helical Triple phase Computerized Tomography (CT): 
 Helical CT was performed in 12 (80 %) patients out of 15 patients under 
study. One of 12, in 6 (50 %) patients helical CT proved useful as diagnostic for 
diagnosis of pseudo aneurysms with a overall diagnostic yield rate of 40 % (6/15). 
CT Angiography: 
 CT angiography in combination Colour Doppler USG was performed in one 
(6.6 %) patient out of 15 under study and it proved to be an useful diagnostic 
investigation in the same one patient for diagnosis of splenic artery pseudo aneurysms 
associated with chronic pancreatitis. Thus, CT angiography has a diagnostic yield rate 
of 100 % in the present series, even though it was done only in one patient. 
Conventional Angiography: 
 Conventional angiography was performed in 10 (66.6 %) out of 15 patients. 
Angiogram was positive in localizing the bleeding point in 8 (80 5) out of 10 patients 
and is proved to be a useful diagnostic modality for diagnosis of bleeding pseudo 
aneurysms. Thus, conventional angiography has an overall diagnostic yield rate of 
53.3 % (8/15). 
Table11. DIAGNOSTIC INVESTIGATIONS PERFORMED IN PATIENTS WITH 
VISCERAL ARTERY PSEUDOANEURYSM – PRESENT SERIES: 
 
 
Radiologic / endoscopic study performed Current series n = 16 
 
Conventional angiography 
 
Helical C T 
 
CT angiography+ Color Doppler USG 
 
Ultrasonography 
 
Plain radiography 
 
Upper gastrointestinal endoscopy 
 
Blood in the duodenum + 
 
Normal endoscopic examination 
 
 
n = 11 (68.75 %) 
 
n= 12 (75.0 %) 
 
n = 1 (6.25 %) 
 
n= 16 (100 %) 
 
n = 5 (31.25 %) 
 
n = 16 (100 %) 
 
n = 3 (18.75 %) 
 
n = 13 (81.25 %) 
 
 
 
 
Method of Diagnosis in Pseudo aneurysmal Bleed: 
 
 The most commonly performed initial diagnostic investigation in the present 
series was helical CT 12/16 (75 %) with a diagnostic yield rate of 50 % (6/12). The 
Next diagnostic investigation that follows helical CT in the present series was 
conventional angiography in 11/16 (68.75 %) patients with a diagnostic yield rate of 
81.1% (9/11). Therefore, our study indicates that in hemodynamic stable patients 
presenting with pseudoaneurysmal bleed an initial helical CT followed by 
angiography would be a better diagnostic approach. 
 
Table 12. METHOD OF DIGNOSIS OF VISCERAL ARTERY PSEUDOAMERYSM 
 
Method of diagnosis Current series n=16 (%) 
 
Conventional angiography (positive) 
 
Helical CT 
 
CT angiography + color Doppler USG 
 
Ultrasonography (USG) and plain radiography 
 
Upper G.I Endoscopy 
 
n = 9/11 (81.8) 
 
n = 6/12 (50 ) 
 
n = 1/16 (6.25) 
 
n = 0 
 
n = 0 
 
 
CT Findings: 
 In pancreatitis group with concomitant pseudocyst (n = 8), the bleeding 
pseudocyst was located at head of pancreas in 3/8 (37.5 %), body of pancreas in 3/8 
(37.5 %), tail in 2/8 (25 %), calcification were seen in 6/8 (75 %), pancreatic duct 
dilatation > 5 mm was seen in 3/8 (37.5 %), evidence of biliary obstruction was found 
in 1/8 (12.5 %) and evidence of gastric outlet obstruction was seen in two patients 2/8 
(25 %). The median (range) size of pseudocyst in this group was 6 (3 -12) cm in 
present series. 
 In the chronic pancreatitis group without associated pseudocyst (n = 3) 
bleeding pseudo aneurysms involving splenic artery located at tail of pancreas was 
seen in 2/3 (66.6 %) and bleeding pseudo aneurysms located at head of pancreas was 
seen in one patient 1/3 (33.3 %). In this group, pancreatic duct dilatation > 5mm was 
not seen in any of 3 patients, pancreatic duct stent was seen in one patient with 
calcification of the entire pancreas in the same patient. 
Table.13 CT FINDINGS IN PATIENTS OF CHRONIC PANCREATITIS WITHOUT 
ASSOCIATED PSEUDOCYST (n = 3) 
 
Patient No. Pancreatic 
calcifications 
MPD dilations > 
5 mm 
Pseudoaneurysm 
location, size (cm) 
Biliary 
obstruction 
 
Case 2 
+ 
Diffuse entire 
pancreas 
- 
pancreatic duct 
stent in situ + 
 
SA, tail 8 cm 
 
- 
Case 9 - - SPDA, head 2.5 
cm 
- 
Case 15 - - SA, tail, 6 cm - 
SA- Splenic artery, SPDA- Superior pancreaticoduodenal arcade 
 
 In the hemobilia group, liver injury with pseudoaneurysm in right hepatic 
artery was seen in two patients 2/4 (50 %), one patient had a 7cm pseudoaneurysm of 
right hepatic artery with a large blood clot and biloma in right subhepatic space of  
TABLE:14 COMPUTERISED TOMOGRAPHIC SCAN FINDINGS IN PATIENTS ACUTE / 
CHRONIC PANCREATITIS WITH CONCOMITANT PSENDOCYST: (n = 8) 
 
Patient No. Bleeding pseudocyst 
Location / Size, cm 
Calcifications MPD 
dilatation 
> 5 mm 
 
Biliary 
Obstruction 
G.O.O 
Case 1 Tail; 4x5x4 + - - - 
Case 5 Body; 12x9x5 - - - - 
Case 6 Head; 3x3x5 + + - - 
Case 8 Head; 6x7x7 
portahepatis 
- + + + 
Case 10 Body; 7x8x9 + - - - 
Case 11 Body;6x5x5 + - - - 
Case 12 Tail; 4x3x3 + - - - 
Case 14 Head; 7x7x8 + + - + 
G.O.O-Gastric outlet obstruction 
size 10 x 9 cm following laparoscopic cholecystectomy, and another one (25 %) had 
pseudoaneurysm of right hepatic artery of size 5cm following laparoscopic 
cholecystectomy. The median (range) size of right hepatic artery pseudoaneurysm 
was 6.25 (2-9) cm and one patient had 8 x7 cm pseudoaneurysm of hepatic artery 
proper following pancreaticoduodenectomy.  
TABLE:15 COMPUTERSIED TOMOGRAPHIC FINDINGS IN PATIENTS WITH 
HEMOBILIA:  
                            
 
Patient No.  
(n = 4) 
 
CT grade- Liver injury 
 (laceration) 
Pseudoaneurysm 
Location/size 
Biloma/blood clot size 
Case 3 Grade II Right hepatic artery, 5 cm - 
 
Case 4 
-  
Right hepatic artery, 7 cm 
Biloma with large blood 
clot in right subhepatic 
space+, 10 x 9 cm 
Case 7 - Right hepatic artery, 2 cm - 
Case 13 Grade III Right hepatic artery, 5 cm - 
 
 
Angiography findings at selective celiac/mesenteric angiography: 
 Conventional angiography demonstrated the site of bleeding (positive 
angiograms) in 9(81.8 %) patients out of 11 patients in whom angiographic 
interventions in this series. Two angiograms (18.1 %) were negative. Angiographic 
source of bleeding was identified in 9 patients – two from splenic artery (case 10, case 
15); two from right hepatic artery (cases 7, 13); two from gastroduodenal artery (cases 
6,14); and one from inferior pancreaticoduodenal artery (case 8) , one from superior 
pancreaticoduodenal arcade (case 9)and one from hepatic artery proper.  
 In general, a positive angiogram was taken as radiologic demonstration of 
pseudoaneurysm or active extravasation of contrast during the arterial phase. The 
positive angiographic findings included active contrast extravasation 
(n=1),pseudoaneurysm (n=6) and combination of contrast extravasation and 
pseudoaneurysm (n=2). 
Etiology of pseudoaneurysmal bleed: 
 Most common pancreatic inflammatory disease associated with 
pseudoaneurysmal bleed in the present series was alcoholic chronic pancreatitis 
(43.75 %). Among 11 patients with pancreatitis; 8 (72.7%) patients had pseudocysts 
and 3(27.2 %) had pseudo aneurysmal bleed complicating CP in the absence of 
associated pseudocyst. In the pseudocyst group (n = 8) ,7(87.5 %) patients had 
recurrent episodes of pancreatitis with a median (range) of 3 (2 to 4) episodes and all 
these 7 patients had prior pseudocysts and in the remaining one (12.5 %) patient, 
pseudocyst formation and hemorrhage occurred with the first episode of acute 
pancreatitis itself. Thus the commonest cause for pseudoaneurysmal bleed was 
bleeding  pseudocyst 6/8 (75 %) in the background of acute/chronic pancreatitis.  
TABLE:16 ETIOLOGY OF PSEUDOANEURYSM-PRESENT SERIES: 
 
ESWL-Extracorporeal shockwave lithotripsy 
 
Preoperative / Pre-embolization Diagnosis: 
 In the present series, most common preoperative or pre-embolization diagnosis 
in a patient presenting with pseudo aneurysmal bleed in the setting of  chronic 
pancreatitis with or without associated pseudocyst is  hemosuccus pancreaticus which 
accounts for 80.0 % (8/10). In the present study, endoscopic examination identified 
blood emanating from the ampulla of vater into the second part of the duodenum in 
3(25.0%) patients[ two (16.6 %) in hemosuccus pancreaticus group and one(8.3%) in 
Etiology Total no. of Patients 
n=16 
Acute alcoholic pancreatitis 1(6.25%) 
Alcoholic chronic pancreatitis 7(43.75%) 
Tropical chronic pancreatitis 2(12.5 %) 
Iatrogenic trauma (n=4)  
       Operative trauma 3 (18.75%) 
. post pancreaticoduodenectomy 
               . post laparoscopic cholecystectomy 
1(6.25 %) 
2(12.5 %) 
       Procedural trauma 
               . post pancreatic ESWL & Pancreatic duct stenting  
 
1(6.25 %) 
Accidental trauma 
               . Blunt liver trauma 
 
2(12.5%) 
hemobilia group]. This indicates that upper  gastrointestinal endoscopy may be useful 
in the diagnosis of hemosuccus pancreaticus in 16.6 % of cases. 
 
TABLE:17 PRE–EMBOLIZATION / PREOPERATIVE DIAGNOSIS IN PATIENTS WITH 
PSEUDOANEURYSMAL   BLEED – PRESENT SERIES 
 
 
Diagnosis 
 
Total No. n = 16 
 
Hemosuccus pancreaticus 
Hemobilia 
Pancreatic pseudoaneurysmal  
bleeding complicating acute/chronic pancreatitis 
 
Bleeding pseudoaneurysm following 
pancreaticoduodenectomy  
 
n = 8 (50.0%) 
n = 4(25.0 %) 
n = 3 (18 75) 
 
 
n=1(6.25%) 
 
Previous Surgery / Procedure done in patients under study were depicted in table-18 
 
 
TABLE-18 PREVIOUS SURGERY / PROCEDURE DONE IN PATIENTS UNDER STUDY: 
 
Previous Surgery / Procedure Total No. n = 6 
Splenectomy for splenic cyst 
(chronic pancreatitis group) 
 
n=1 
Pancreatic duct 
Stenting + ESWL for pancreatic duct calculi 
(chronic pancreatitis group) 
 
n=1 
Biliary tract surgery (n=3) 
Open cholecystostomy + CBD exploration + T-
tube drainage for blunt liver trauma 
(Hemobilia group) 
Laparoscopic cholecystectomy for stone disease 
(Hemobilia group) 
 
n=1 
 
 
 
n=2 
Pancreatic surgery 
Whipple’s pancreaticoduodenectomy 
 
n=1 
 
 
Bleeding Vessel implicated in patients with Pseudo aneurysmal bleeding: 
 
 In the present series, splenic artery is the most commonly involved vessel 6 
(37.5 %) followed by  hepatic artery in 5 (31.25 %).[Table19]       
Site of Pseudo aneurysmal bleeding according to location of Pseudo aneurysm. 
 
 In the present series, the commonest site of pseudo aneurysmal bleed was into 
the pseudo cyst in 6 (37.5 %) followed by biliary tract in 4 (25.0%).[Table 20] 
TABLE-19 Blood vessel implicated in visceral artery pseudoaneurysmal bleeding 
– Comparative analysis of current series with published series. 
 
Vessel   
involved 
Current series 
n = 16 
percentage 
Stabile et al 
1998 
n = 344 
Percentage 
Carr et al 
n = 16 
percentage 
 
Beattie et al 
2003 
n = 19 
percentage 
 
Splenic artery 
 
Gastroduodenal 
artery 
 
Pancreatico 
duodenal artery 
 
Hepatic artery 
 
Left gastric artery 
 
Right gastric artery 
 
Dorsal pancreatic 
artery 
 
Transverse 
pancreatic artery 
 
Superior mesenteric 
artery 
 
Middle colic artery 
 
37.5 
 
12.5 
 
12.5 
 
 
31.25 
 
- 
 
- 
 
- 
 
- 
 
 
 
- 
 
 
6.25 
 
36.9 
 
18.0 
 
19.2 
 
 
2.6 
 
2.6 
 
1.2 
 
7.0 
 
 
3.5 
 
 
2.6 
 
 
0.6 
 
18.7 
 
37.5 
 
12.5 
 
 
- 
 
- 
 
- 
 
- 
 
 
- 
 
 
6.25 
 
 
- 
 
 
 
15.7 
 
21.0 
 
21.0 
 
 
- 
 
10.5 
 
- 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
Features of Pseudoaneurysm: 
 
 In patients with chronic pancreatitis, the mean (range) size of pseudoaneurysm 
was 5.1 (2 to 10) cm and were contained by the pseudocysts in 7 out of 10 patients. In 
patient with acute pancreatitis, the size of the pseudo aneurysm was 10 cm which was 
contained by the pseudocyst in the vicinity of acute inflammation of pancreas. In 
patients with hemobilia, the mean (range) size of pseudo aneurysm was 5.8 (2-9)cm. 
In all the patients the number of pseudo aneurysm was single. The pseudo aneurysm 
sac was intact in 13 patients and it was  ruptured in 2 patients (one in hemobilia group 
– right hepatic artery pseudo aneurysm ruptured into biliary tract and right sub hepatic 
space and in another one patient in the acute pancreatitis group – middle colic artery 
pseudo aneurysm was ruptured into the leaves of right colon mesentery and presented 
as mesenteric hematoma. 
 The mean (range) size of the pseudoaneurysm in patients (n = 5 ) who  
underwent operative interventions as first line therapy without prior angiography was 
7.8 (5-10)cm and in patients ( n = 6 ) who required operative interventions as second 
line therapy for secondary complications or failure after angiographic embolization 
was 7.1 (3-9)cm in the present series. 
 
 
TABLE-20 Site of pseudoaneurysmal bleeding according to the location of 
pseudoaneurysm. 
 
 
Location of pseudoaneurysm 
 
Primary site of bleeding 
 
Splenic artery 
(n= 6)(37.5%) 
Peritoneal cavity – 1 
Pseudocyst           - 2 
(Intracystic) 
Wirsung duct       - 1 
Stomach               - 1 
Transverse colon and left lung -1 
 
Right hepatic artery 
(n = 4)(25%) 
Extrahepatic bile duct -2 
 
Intrahepatic biliary tree – 2 
 
Gastro duodenal artery 
(n = 2)(12.5%) 
 
Pseudocyst – 2 
(Intracystic) 
Superior pancreaticoduodenal arcade 
(n = 1) (6.25%) 
Wirsung duct 
Middle colic artery 
(n = 1) (6.25%) 
 
Pseudocyst 
(Intracystic, intra-abdominal) 
Hepatic artery proper 
(n = 1) (6.25%) 
 
Abdominal wall sinus  
 
 
Thus, the overall mean  (range) size of pseudoaneurysm that required 
operative intervention was 7.4 (3-10) cm in the present study. The mean (range) size 
of the pseudoaneurysm in patients (n=4) who underwent angiographic embolization 
as first line definite therapy was 2.3 (2-3) cm in the present series. 
TABLE-21 PSEUDOANEURYSM-FEATURES 
Patient 
No. 
 
Source of 
bleed/ vessel 
involved 
Size 
Median (range) 
5 (2-10) cm 
Number 
(single/multiple) Ruptured/Intact 
1 SA 7 Single Intact 
2 SA 8 Single Intact 
3 RHA 5 Single Intact 
4 RHA 9 Single Ruptured into right sub-hepatic 
space & biliary tract 
5 MCA 10 Single Ruptured into leaves of right 
colonic mesentery 
6 GDA 3 Single Intact 
7 RHA 2 Single ruptured 
8 IPDA 2 Single Intact 
9 SPDA 2.5 Single Intact 
10 SA 8 Single Intact 
11 SA 9 Single Intact 
12 SA 3 Single Intact 
13 RHA 7.5 Single Intact 
14 GDA 7 Single Intact 
15 SA 8 Single Intact 
 
16 
 
HAP 
 
8 
 
Single 
Intact, Communicating with 
abdominal wall sinus tract 
SA-Splenic artery, GDA – Gastroduodenal artery, RHA – Right hepatic artery, IPDA – Inferior pancreaticoduodanal artery, 
SPDA – Superior pancreaticoduodenal arcade, HAP-Hepatic artery proper   
 
This indicates that for small pseudoaneurysm (< 3cm), angiographic embolo-
therapy is often sufficient as a primary definite therapy in order to achieve permanent 
hemostasis but for large pseudoaneurysm (>7cm), PTAE is usually contemplated as 
an initial temporizing measure and it most often requires subsequent surgical 
intervention in the form of either excision or drainage procedure as soon as possible 
after PTAE. The mean size of the pseudoaneurysm in relation to underlying etiology 
of disease either pancreatitis related or trauma related is almost similar (5.75 to 5.80 
cm) in both groups in the present study. 
 
 
 
 
Comparative analysis of pancreatic pseudo aneurysm with / without associated 
pseudocyst: 
In the present study, 8 (72.7%) patients had pancreatic pseudoaneurysm with 
concomitant pseudocyst. Interventions as  successful therapy  in this group included 
surgery in 75% and percutaneous trans-catheter angiographic embolization(PTAE)  in 
25%.In the present study, failure rate of PTAE was 66.6% in patients having 
pseudoaneurysm with associated pseudocyst ,with no embolization failure in patients 
without pseudocyst. The average size of pseudoaneurysm without associated 
pseudocyst in which embolization (PTAE) successful was 5.2cm with no failure of 
embolization. The average size of pseudoaneurysm with associated pseudocyst in 
which embolization failed was 6.75cm, compared with 2.5cm in those in which it was 
successful. None of the patients with pseudo aneurysm were managed conservatively 
in the present series. Based on the comparative sub group analysis, it was found that 
pseudoaneurysm associated with pseudocyst often requires surgical intervention in the 
form of resection, excision or ligation rather than trans-catheter angiographic 
embolization. 
Angiographic interventions for hemostasis in pseudo aneurysmal bleed: 
 Angiography was performed in 11 (68.75%) of 16 patients in the present 
study. Angiographic catheter directed therapeutic embolization was attempted in 9 
(81.8 %) of 11 patients and was successful in achieving hemostasis in 6 of 9 patients 
with an  overall embolization rate of 66.6%. Percutaneous trans-catheter angiographic 
embolization (PTAE) as first line / initial definitive therapy with no further 
intervention for hemostasis was performed in 5/9 (55.5%) hemodynamically stable 
patients. PTAE as initial temporizing measure for hemostasis requiring subsequent 
operative therapy was achieved in one patient 1/6 (16.6 %).PTAE was achieved in 6 
patients (selective n=4,superselective n=2 )using embolic agents  such as coils 
(n=5);autologous blood clot and gelatin sponge (n=1).The embolized arteries were 
Splenic artery(n=1),gastroduodenal artery (n=2),superior pancreatico duodenal artery 
(n=1),inferior pancreatico duodenal artery  (n=1) and  right hepatic artery(n=1).[table 
22] 
TABLE:22 ANGIOGRAPHIC INTERVENTIONS FOR HEMOSTASIS IN 
PSEUDOANEURYSM BLEED: 
Angiography performed 
n = 11/16 (68.75 %) 
Total No. 
n=16 
Therapeutic catheter directed embolization 
attempted  
 
n = 9/11 (81.8 %) 
PTAE technically successful  n=6/9(66.6%) 
PTAE successful as first line / initial definitive 
therapy with no further intervention for 
hemostasis (permanent hemostasis) 
 
5/9 (55.5 %) 
PTAE as successful as initial temporizing 
measure for hemostasis requiring subsequent 
operative therapy for re-bleed (temporary 
hemostasis) 
6(16.6%) 
 
PTAE as second line / delayed definitive therapy 
after the initial failed surgery. 
n = 0 
PTAE attempted and failed as initial first line 
therapy (technical failures) 
n = 3/9 (33.3%) 
 
Surgical interventions for hemostasis in pseudo aneurysmal bleed:  
 Surgical interventions were required in 12 (75.0 %) of 16 patients. In the 
present study, surgery as first line/initial definitive therapy without prior angiography 
and with no further / subsequent intervention for hemostasis was achieved in 5/12 
(41.6 %), 4 emergency and 1 elective.  
 In the present series, surgery as second line/delayed therapy for 
failure/complications of angiographic embolization was performed in 6/12 (50.0 %), 2 
emergency and 4 elective. [Table 23] 
TABLE: 23 SURGICAL INTERVENTIONS FOR HEMOSTASIS IN PSEUDOANEURYSM 
BLEED: 
Surgical interventions n 
= 12/16 (75.0 %) Total No. n = 12 
Emergency / urgent 
surgery n= 6 (50.0 %) 
Elective surgery n = 6 
(50.0 %) 
Surgery as first line / 
initial definitive therapy 
with no further 
intervention 
5/12 (41.6 %) 4 1 
Surgery as second line 
/delayed therapy for 
failure / complications 
of angiographic 
embolisation  
6/12 (50.0 %) 2 4 
Combined operative 
therapy and 
angiographic embolo 
therapy for rebleeding 
after embolisation. 
1/12 (8.3 %) - 1 
 
Indications for Surgery: 
 The most common indication for urgent surgery as first line therapy in the 
present series was major bleeding with significant hemodynamic instability and rapid 
clinical deterioration due to continued bleeding in 4 patients.[Table24] 
TABLE : 24 INDICATIONS FOR SURGERY: 
Indications Total No. n = 12/16 (75.0 %) 
Active bleeding with significant haemodynamic 
instability and rapid clinical deterioration (unsuitable 
for angiography)  
n= 4 (33.3 %) 
(all emergency surgery) 
Failure of angiographic  embolization 
Technical failures (n=3) 
Rebleeding (n=1) 
n = 6 (50.0 %) 
(2 emergency, 4 elective) 
 
Complication of angiographic embolization  
(Infection of thrombosed residual pseudoaneurysm 
with intra abdominal sepsis) 
n = 1 (8.03 %) 
(elective surgery) 
 
Post laparoscopic cholecystectomy combined right 
hepatic artery injury with bleeding pseudoaneurysm, 
worsening anaemia and major bile duct injury with 
biliary and intra abdominal sepsis. 
n = 1 (8.03 %) 
(emergency surgery) 
 
Operative Findings: 
 At surgery, morphological changes of acute pancreatitis with hematoma in 
right colon mesentry following rupture of middle colic artery pseudo aneurysm was 
seen in one patient (case5).  
 At surgery morphological changes of chronic pancreatitis with fibrosis in 4, 
calcification in 6, and mature pseudocysts in 5 patients in 5 patients respectively. At 
surgery, one patient (case 4) had biloma with a large 9 cm sized blood clot in right 
subhepatic space following rupture of right hepatic artery pseudo aneurysm due to 
post-laparoscopic cholecystectomy right hepatic artery injury and major bile duct 
injury. 
TABLE : 25TYPES OF OPERATIVE PROCEDURES: 
 
Operative procedure Total No. n = 11 
Central / middle segment pancreatectomy with excision of SA 
pseudoaneurysm 
n = 1 
(case – 10) 
Transection of body of pancreas with intracystic ligation of gastro duodenal 
artery with excision of GDA pseudoaneurysm + external drainage of 
pseudocyst cavity, suture closure of proximal pancreatic stump with distal 
Roux-en-Y pancreatico jejunostomy. 
n = 1 
(case 14) 
Intracystic ligation of splenic artery with excision of SA pseudoaneurysm 
and cystogastrostomy. 
 
n = 1 
(case 11) 
Distal pancreatectomy and splenectomy with excision of SA 
pseudoaneurysm + suture closure of proximal pancreatic remnant. 
n = 2 
(case )  (1,2) 
Distal pancreatectomy and splenectomy with excision of SA 
pseudoaneurysm + proximal Roux-en-y pancreatico jejunostomy. 
n = 1 
(case 12) 
External drainage of infected thrombosed residual SA pseudoaneurysm with 
retroperitoneal abscess. 
n = 1 
(case 15) 
Right hepatectomy for RHA pseudoaneurysm(Hemobilia following blunt 
liver trauma   
n = 2 
(case 3,13) 
Excision of RHA pseudoaneurysm with suture repair of bleeding vessel and 
bile duct intubation 
n = 1 
(case 4) 
Right hemicolectomy with mesenteric hematoma evacuation, extracystic 
vessel ligation and external drainage of pseudocyst for rupture of middle 
colic artery pseudoaneurysm into acute  pseudocyst. 
n = 1 
(case 5) 
Excision of pseudoaneurysm, suture repair of bleeding vessel and proximal 
ligation of common hepatic artery for hepatic artery proper pseudoaneurysm 
following pancreaticoduodenectomy. 
n=1                         
(case 16) 
 
 
 Another one patient (case 2) had a large 8 cm sized  splenic artery pseudo 
aneurysm in the body of pancreas communicating with left lung through a rent in left 
dome of diaphragm and also had communication with transverse colon due to pseudo 
aneurysm erosion. Another one patient had a post pancreatico duodenectomy large 8 
cm sized   pseudoaneurysm (case16) arising from hepatic artery proper, which was  
located behind the Roux-en –Y jejunal limb of hepaticojejunostomy communicating 
with the anterior abdominal wall sinus through a sinus tract. 
Operative Procedures: 
 The various operative procedures performed were depicted in the table- 24. 
 
 
FLOWCHART-1 Results and outcome of diagnostic angiography and therapeutic angiographic 
embolization: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results and outcome of angiographic interventions: 
 In the present series, 9(81.8%) of 11 patients who underwent coelic / 
mesenteric angiography, angiogram  localized either a bleeding point in 33.3% 
(n=3)or a pseudo aneurysm in 66.6 % (n=6) and in 2 (18.1%) of patients angiography 
could not localize the bleeding point. Angiographic embolization was attempted in 
Pancreatic 
pseudoaneurysms (n=11) 
Without associated pseudocyst 
n = 3 (27.2 %) 
With associated pseudocyst 
n= 8 (72.7 %) 
Attempted n = 2  
Not attempted
n = 1 
Not attempted  
n = 2/8 (25%) 
MP   n =1 
DP   n =2 
ICL + ED    n=1 
ICL + CG    n=1 
Rebleed: 1 (16.6%) 
Mortality - 0 
PTAE 
PTAE Surgical interventions n= 6 
Failed n = 4/6
(66.6 %) 
Attempted  
n= 6/8 (75 %) 
AP  n = 1  (9.0 %) 
Alcoholic CP n = 5 (45.4 %)
Tropical CP n = 2 (18.1 %) 
Technical Success 
n=3/6  (50 %) 
Clinical Success 
n=2/6 (33.3 %) 
For  SA 
pseudoaneurysm 
For MCA 
pseudoaneurysm 
RHC & ECL 
 + ED     n =1 
Alcoholic CP 
n=3 
Surgical 
intervention  
n=1
Technical & Clinical success 
n=2 
DP      
n=1 
Rebleed: 0 
Mortality - 0 
MP- Middle Segment/central pancreatectomy 
DP- Distal pancreatectomy 
ICL + ED - Intracystic ligation & External Drainage 
ICl + CG - Intracystic ligation + cystogastrostomy 
RHC & ECL + ED- Right hemicolectomy + Extracystic ligation and external drainage 
SA- splenic artery 
MCA - middle colic artery 
AP – Acute pancreatitis 
CP – Chronic pancreatitis 
PTAE – Percutaneous Transcatheter Arterial Embolization
9/11 (81.8 %) and was successful in 6/9 (66.6%) with an overall technical success rate 
or embolization rate of 66.6 % in the present series.[Flow chart 2] 
TABLE-26 Outcome of angiographic embolization according to the type and number of embolic 
agents and method of coil deposition 
 
Method of coil deposition / 
deployment 
 
 
 
Patient 
No: 
 
 
 
Vessel 
involved 
 
 
 
Embolizat
ion 
Material 
 
Inside 
PA 
On 
either 
side of 
PA 
(Proxim
al and 
distal to 
PA) 
 
On the 
feeding 
artery 
 
 
Size/ 
Number 
coils 
used 
 
 
 
Immediate 
response 
 
 
 
Clinical 
outcome 
Case 6 
 
 
 
Case 7 
 
 
Case 8 
 
 
Case 9 
 
 
Case 14 
 
 
Case 
15 
GDA 
 
 
 
RHA 
 
 
IPDA 
 
 
SPDA 
 
 
GDA 
 
 
 
SA 
Microcoils 
 
 
 
Tungsten 
coils 
 
 
Microcoils 
 
 
Microcoils 
 
 
Microcoils 
 
 
 
Autologou
s blood 
clot and 
gel foam 
pledgets. 
- 
 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
 
√ 
√ 
 
 
 
- 
 
 
- 
 
 
- 
 
 
√ 
 
 
 
- 
 
 
 
 
 
 
 
- 
 
 
 
√ 
 
 
√ 
 
 
√ 
 
 
- 
 
 
 
- 
 
 
 
 
3mm, 3 
 
 
 
3mm, 2 
 
 
2mm,2 
3mm,3 
 
3mm,2 
 
 
5mm,4 
 
 
 
- 
 
 
Stop 
bleeding 
 
 
Stop 
bleeding 
 
Stop 
bleeding 
 
Stop 
bleeding 
 
Stop 
bleeding 
 
 
Stop 
bleeding 
Favorable 
 
 
 
Favorable 
 
 
Favorable 
 
 
Favorable 
 
 
Rebleed 
(due to 
SMA 
collaterals 
to PA) 
 
Sepsis of 
residual 
thrombosed 
PA 
 
PA - pseudoaaneurysm 
 
 
 5 of 11 patients who had positive angiograms required subsequent surgical 
interventions, in three patient with technical failure due to non–cannulation of 
bleeding artery and in two (18.1%) patient due to non -demonstration of angiographic 
source of bleeding with a overall technical failure rate of 33.3% (3/9) in the present 
series. In the present study splenic artery embolization is associated with a high 
failure rate of 75%, and embolization of pancreaticoduodenal artery is associated with 
a success rate of 100%. [Table 27] 
 In the present series, coil embolization is associated with high success rate of 
80% (4/5) when compared with other embolic agents[Table 26]. In the embolization 
group (n = 6), angiographic embolization was successful as primary definitive therapy 
for achieving permanent hemostasis with no further intervention for bleeding in 5 
/9(55.5%) patients and one (16.6 %) patient had rebleeding after  successful 
embolization requiring subsequent elective surgical intervention. Thus, the overall 
clinical success rate for  embolization to provide definitive hemostasis was 55.5 % in 
the present series. None of the patients developed late rebleeds in the present series.  
One patient developed a complication related to embolization i.e infection of 
thrombosed residual pseudoaneurysm with retroperitoneal abscess and intra-
abdominal sepsis 14 days after embolization and required subsequent elective surgical 
intervention.One patient with GDA pseudo aneurysm within a pseudocyst had rebleed 
48 hours after embolization due to persistent leak into the pseudo aneurysm through 
superior mesenteric artery collaterals and subsequently required elective surgical 
intervention. Thus the overall morbidity rate, excluding technical failure following 
PTAE was 16.6 %(1/6) and rebleeding rate was 16.6% (1/6)in the present study with 
no mortality.[Table 28] 
OUTCOME OF SURGICAL INTERVENTIONS: 
 None of the patients had rebleed after surgery either in the group of first line 
or second line operative therapy with an overall success rate of 100 %. Among 12 
patients who underwent surgery, 6 emergency and 6 elective, none of the patients died 
in post operative period. The major surgical morbidity included, external pancreatic 
fistula in two (16.6 %) patients with a overall morbidity rate of 41.6% (5/12). The two 
patients who had external pancreatic fistula were managed conservatively and it 
healed spontaneously over a period of 3 months after surgery. [Table 29-30] 
FLOW CHART -2 DEMONSTRATING OUTCOME IN RELATION TO ANGIOGRAPHIC 
FINDINGS: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TABLE -27 Result of embolization according to the site of artery involved: 
 
Artery involved Total No: 
Embolization
Attempted 
Embolization
Successful Failure rate 
 
Splenic artery 
 
Hepatic artery 
(RHA,HAP) 
Gastro duodenal 
artery 
 
Pancreatico 
duodenal arcade 
 
n = 6 
 
n = 6 
 
n = 2 
 
 
n = 2 
 
n = 4 
 
n = 3 
 
n = 2 
 
 
n = 2 
 
n = 1 
 
n = 1 
 
n = 2 
 
 
n = 2 
 
 
75% 
 
33.3% 
 
50% 
(Rebleed) 
 
0% 
 
 
 
Number of patients in present series 
                            n= 16 
                  Angiography attempted  
                        n = 11 (68.75 %) 
Positive findings at 
Angiography. (Bleeding point 
demonstrated) 
n = 9( 81.8 %) 
Negative findings at 
angiography n = 2 (18.1 %) 
(no angiographic source of 
bleed)  
Embolization 
successful 
n = 6 
Embolization  
Failed  
n = 3 
Blind 
embolization  
n = 0 
No 
embolization 
(not attempted) 
n = 2  
Rebleed 1 (16.6 %) 
Mortality 0 
Rebleed 3 (100 %)
Mortality - 0 
Rebleed – 0 
Mortality - 0 
Rebleed 2 (100 %) 
Mortality - 0 
TABLE-28 RESULTS OF ANGIOGRAPHIC INTERVENTIONS IN PATIENTS WITH 
PSEUDOANEURYSMS: 
 
Patien
t No 
Disease 
Status 
Active 
bleeding 
during 
angio 
Angio 
findings 
Vessels 
embolized 
Embolic 
Material used 
Reblee
d 
Urgent 
Surger
y 
Electiv
e 
surgery 
Outcome  
 
 
Case 6 
 
 
PS & CP 
 
Yes 
Angio 
positive 
 
Pseudo 
aneurysm 
GDA 
 
 
GDA 
 
 
Microcoils 
 
 
No 
 
 
No 
 
 
No 
Survived, 
resolution of 
pseudocyst at 
3 months 
 
 
Case 7 
 
 
Post–
Lap. 
Chole  
 
 
Yes 
Pseudo 
aneurysm 
RHA, 
Angio 
positive 
 
 
RHA 
 
 
Tungsten coils 
 
 
 
No 
 
 
No 
 
 
 
 
No 
Survived, 
resolution of 
pseudoaneury
sm, no 
rebleed 
Case 8 
 
PS & CP 
 
 
 
Yes 
 
 
Pseudo 
aneurysm 
IPDA, 
Angio 
positive 
 
IPDA 
 
 
 
Microcoils 
 
 
No 
 
 
No 
 
 
 
 
No 
 
 
Survived,reso
lution  of 
pseudocyst at 
2 months 
after PCD 
Case 9 
 
 
 
CP Yes, 
Angio 
positive 
 
Pseudo 
aneurysm 
SPDA 
 
SPDA, 
 
 
Microcoils 
 
No 
 
No 
 
No 
 
Survived 
 
 
Case 
10 
 
 
PS & CP 
 
 
No 
 
 
Angio 
negative 
 
 
        - 
 
 
 
 
- 
 
 
 
Yes 
 
 
- 
 
 
Yes 
 
 
Survived 
 
 
Case 
11 
 
 
PS & CP 
 
 
Yes, 
Angio 
positive 
 
 
Pseudoan
eurysm 
SA 
 
 
Failed 
cannulation 
of bleeding 
artery 
 
 
None 
 
 
 
 
 
Yes 
 
 
 
 
 
Yes 
 
 
 
 
 
No 
 
 
 
 
 
Survived 
 
Case 
12 
 
PS & CP 
 
No 
 
Angio 
negative 
 
     - 
 
 
 
None 
 
 
 
Yes 
 
 
 
No 
 
 
 
Yes 
 
 
 
Survived 
 
 
Case 
13 
 
 
Hemobil
ia Blunt 
liver 
trauma 
 
 
Yes, 
 Angio 
positive 
 
 
 
Pseudo 
aneurysm 
RHA 
 
 
Failed 
cannulation 
of bleeding 
artery 
 
 
None 
 
 
Yes 
 
 
Yes 
 
 
- 
 
 
Survived 
 
Case 
14 
 
PS & CP 
 
Yes, 
Angio 
positive 
 
Pseudo 
aneurysm 
GDA 
 
GDA 
 
Microcoils 
 
Yes 
 
No 
 
Yes 
Survived, 
resolution  of 
pseudocyst at 
5 months  
Case 
15 
CP Yes, 
Angio 
positive 
 
Pseudo-
aneurysm 
SA 
SA Autologous 
blood clot and 
gel foam 
particles 
No - Yes Survived, 
infection of 
thrombosed 
PA 
Case 
16 
Post-PD No HAP 
pseudoan
eurysm 
Failed 
cannulation 
- No - Yes survived 
 
CP – Chronic pancreatitis, PS – Pseudocyst, SA – Splenic artery, GDA – Gastroduodenal artery, RHA – Right hepatic artery, 
IPDA – Inferior pancreaticoduodenal artery, SPDA – Superior pancreaticoduodenal arcade, HAP – hepatic artery proper, PCD-
percutaneous catheter drainage PA-pseudoaneurysm 
 
 
 
 
TABLE-29 OUTCOME OF PATIENTS WHO UNDERWENT SURGICAL INTERVENTIONS:  
(n = 12) 
 
Patient 
No. Morbidity/Mortality Final Outcome 
Results of F /U CT 
Case 1 None, alive No rebleed, chronic pancreatitis at 48 months 
Evidence of chronic 
pancreatitis  at 40 
months 
Case 2 None, alive No rebleed, chronic pamcreatitis at 36 months 
Evidence of chronic 
pancreatitis  at 30 
months 
Case 3 None, alive No rebleed, asymptomatic at 3 months 
Good liver regeneration 
at 18 months 
Case 4 None, alive No rebleed, asymptomatic at 2 months 
No evidence of biliary 
dilatation at 4 months 
Case 5 External pancreatic fistula, alive No rebleed, asymptomatic at 20 months 
Resolution of 
pseudocyst at 16 months 
 
Case 10 
 
Alive, wound sepis 
 
No rebleed, pain free at 12 
months 
 
Resolution of 
pseudocyst at 10 months 
Case 11 None, alive No rebleed, pain free at 11 months 
Resolution of 
pseudocyst at 7 months 
Case 12 None, alive No rebleed, chronic pancreatitis at 36 months 
Resolution of 
pseudocyst at 12 months 
Case 13 Pneumonia, alive No rebleed, asymptomatic at 3 months 
Good liver regeneration 
at 14 months 
 
Case 14 External pancreatic fistula, alive No rebleed, asymptomatic pain free at 20 months 
Resolution of 
pseudocyst at 19 months 
Case 15 
 None, alive 
No rebleed, asymptomatic 
at 28 months 
Evidence of chronic 
pancreatitis  at 18 
months with a new 
pseudocyst(2.5cm) in 
tail 
Case 16 None, alive No rebleed Resolution of pseudoaneurysm 
 
 
OVERALL OUTCOME: 
 There were no post operative deaths in both angiographic and operative 
intervention groups of patients.Control of bleeding was successful in all patients (n = 
10) treated by surgery. There were no recurrence of pseudoaneurysm or bleeding in 
any of the patient during follow up after mean follow up of 26.3 (45 – 59) 
months.[Table 28,29,30,31] 
  
TABLE-30  Overall outcome of surgical interventions 
 
 
Outcome parameter 
 
n =12 (%) 
 
 
Morbidity 
Pneumonia 
Wound sepsis 
External pancreatic fistula 
Intra abdominal fluid collection 
Mortality 
Rebleeding 
Success rate 
Overall morbidity rate 
 
 
 
1 (8.3) 
1 (8.3) 
2 (16.6) 
1 (8.3) 
0 
0 
100% 
5(41.6) 
 
 
TABLE-31 OVERALL OUTCOME OF ANGIOGRAPHIC INTERVENTIONS: 
 
Result Total No.n=11 
 
Patients underwent celiac / mesenteric angiography 
 
 
n = 11/16 (68.75 %) 
 
 
Embolization attempted with positive angiogram 
 
n = 9/11 (81.8 %) 
 
Angiography localized either a bleeding point or a 
pseudoaneurysm (Detection rate) 
 
 
n=9/11 (81.8%) 
 
 
Technical success rate  (embolization rate) n = 6/9 (66.6%) 
Technical failure rate n= 3/9 (33.3 %) 
Non-demonstration of bleeding point 
Non-cannulation of bleeding artery 
n = 2/11 (18.1 %) 
n = 3/9 (33.3 %) 
Complication related to embolization 
Infection of thrombosed residual pseudoaneurysm n = 1/6 (16.6 %) 
Overall  clinical success rate of  embolization  with no 
further intervention for bleeding control 
n= 5/9 (55.5 %) 
 
Rebleeding after initial successful embolisation n = 1/6 (16.6 %) 
Morbidity rate n = 1/6 (16.6 %) 
Rebleeding rate n = 1/6 (16.6 %) 
Survival rate is embolisation group n=6/6 (100 %) 
Overall failure rate of PTAE including technical failure           
and rebleed 
n=4/9 ( 44.4%) 
 
 
 
Late Survival and Follow-Up: 
 Follow up data were available for 14of 16 survivors, with a mean follow up of 
26.3  (range 45 – 59 )months. Two patients (case 7, case 8) were lost to follow up at 5 
and 11 months. Follow up CT scans were obtained in 8 patients at a mean interval of 
12 months (range, 1- 40) months, which demonstrated resolutions of pseudocyst in 4 
patients. In one patient (case 15), a new 2.5 cm pseudocyst was discovered at 18 
months in a patient who has alcoholism and chronic pancreatitis. No  pseudoaneurysm 
recurred in any patient during follow up. None of the patient had late rebleeds during 
follow up.[Tables 28,31] 
 
DISCUSSION AND COMPARATIVE ANALYSIS: 
 Our series of 16 patients with visceral artery pseudoaneurysm is a small 
retrospective observational cohort study based on a single institutional experience at a 
tertiary care referral center. In itself this is a indicator of the relative infrequency of 
major vascular complication of pancreatitis and vascular trauma (iatrogenic / 
accidental) to visceral arteries. This low incidence of visceral artery pseudoaneurysm 
as it is a relatively uncommon disease and the urgent nature of major 
pseudoaneurysmal bleeding presenting as a rarely occurring rapidly fatal complication 
probably means that neither randomized trial nor case control methodologies are 
suitable for evaluating outcome and that evidence on optimal management will 
continue to accure from single- institutional, observational cohort series such as the 
present study. 
 Visceral artery pseudoaneurysm is a rare clinical entity. Over 7 years at our 
institution only 16 pseudoaneurysms were identified and 6 involved the splenic artery. 
Review of literature supports the rarity of these lesions. Although, more than 3000 
visceral artery aneurysms have been reported in the literature, only 157 splenic artery 
pseudoaneurysms have been identified. Therefore, good understanding of the risk 
factors, presenting symptoms, diagnostic studies and treatment options is often 
necessary. 
 The mean age of presentation of pseudoaneurysmal bleed in our series was 37 
years which is similar to other series34,38,45  although presentation during childhood has 
also been reported 80,81  and one of our patient was a female child who presented with 
upper gastrointestinal bleed in the background chronic pancreatitis at age of 12 years. 
Clinical presentation varies according to the site and severity of haemorrhage. 
Bleeding is usually brisk, but varies from short, repeated and self limiting episodes of 
haemorrhage, slow and chronic blood loss presenting as iron deficiency anemia, 
moderately severe and intermittent bleeding as a massive haemorrhage with life – 
threatening hypovolaemic shock requiring emergency surgery 48. The most common 
type of clinical presentation in our series was upper gastro intestinal bleeding (81.8 
%) in the pancreatitis group which is comparable to 60 – 69% in other series 40,45,48. In 
the present series, the most common etiology associated with pancreatic 
pseudoaneurysm was pseudocyst in 75.0 %  which is comparable to 60 to 100 % 
reported in other series 40,45. 
Pseudoaneurysm formation in patients with pancreatitis is closely 
related to the intensity and duration of the disease 44,48. The incidence of 
pseudoaneurysm varies between 10 – 17 % in chronic pancreatitis with 
bleeding and is 10 to21 % in patients with chronic pancreatitis without bleeding 
undergoing angiography 34,41,48, but the incidence of pseudoaneurysm was higher 
in patients with pancreatic pseudocyst reported as 10 – 31 % 34,38. Most 
pseudoaneurysms are symptomatic and mostly develop in association with and   
in close proximity to pseudocyst.In general, vascular complications of acute 
pancreatitis occur late in the disease course and in post operative patients. In 
contrast, the data from the present study suggest that patients with vascular 
complications of chronic pancreatitis or of pseudocysts may be admitted to 
hospital with their vascular complication as a presenting symptom. In the 
present study also, post inflammatory peripancreatic pseudoaneurysm 
formation is mostly commonly encountered in alcoholic chronic pancreatitis 
with concomitant pseudocyst particularly in alcoholic men. Major 
gastrointestinal haemorrhage was reported in 1.7 – 10 % of patients with 
pancreatitis and melaena 34,38. Frank rectal bleeding / hematochezia and 
hemoptysis may be related to the rare case of rupture of a pseudocyst / 
pseudoaneurysm into the colon / lung 34,82   which occurred in one of our patient 
(case 2). The incidence of haemorrhagic complications were reported as 7 – 14 
% in patients with chronic pancreatitis 19,21 1-3 % in patients with acute 
pancreatitis and 6 – 31 % in patients with pancreatic pseudocyst 19,21,68,45. 
Bleeding into the pseudocyst may arise from a ruptured pseudoaneurysm or 
from vessels within the wall of the pseudocyst. This in turn lead to rupture into 
the gastrointestinal tract (stomach, duodenum, colon), pancreatic duct, bile 
duct, peritoneal cavity or retro peritoneum34,48 with serious consequences. In 
majority of cases of chronic pancreatitis, bleeding usually originated from a 
pseudoaneurysm or pseudocyst wall..In the present series, the most common 
site of pseudoaneurysmal bleeding was into the pseudocyst 37.5 %  however, a 
substantial number of patients had bleeding into duct of wirsung, bile duct, 
stomach, colon and peritoneal cavity. In addition, 54.5 % of patients with 
bleeding are hemodynamically unstable at presentation. 
 Pancreatitis in both acute and chronic forms is the commonest cause of 
visceral artery pseudoaneurysm particularly in alcoholic males. Pancreatic and peri 
pancreatic vascular structures can become disrupted by the inflammation and 
enzymatic autodigestion of arterial wall by pancreatic enzymes such as trypsin and 
elastase liberated during on-going pancreatitis. Arteries, veins, vessels within the 
pseudocyst wall and the spleen may become involved. When pancreatic and 
peripancreatic vessels come in contact with activated proteolytic enzymes, it results in 
necrotizing arteritis with destruction of vessel wall architecture and the fragmentation 
of its elastic tissue leads on to formation of pseudoaneurysm particularly in the 
presence of secondary infection 18,33. Though the natural history of pseudoaneurysm is 
not well established, rupture is the most likely sequel. Rarely, spontaneous regression 
23,34 of a visceral pseudoaneurysm may occur. The most commonly affected vessel in 
pancreatitis is the splenic artery 23,34,40 followed by, in descending order of frequency 
the gastroduodenal 34,40, pancreatico duodenal, gastric, hepatic and middle colic 
arteries 40which is similar to the present series. 
 Post traumatic pseudoaneurysm formation in the hepatic artery have been 
documented following operative / accidental injury to hepatic artery presenting as 
hemobilia 53. Accidental blunt liver trauma due to road traffic accident causes shearing 
of arteries, veins and bile ducts without capsular rupture resulting in acute 
presentation of hemobilia. Blunt trauma to the liver results in a central rupture that 
may leave a large cavity (cavitation effect) into which damaged bile ducts and blood 
vessels drain 53. The resulting biloma or hematoma may continue to expand while 
liver healing is impaired. Necrosis of the cavity wall may cause erosion of adjacent 
structures particularly the hepatic artery resulting in formation of a pseudoaneurysm 
which may expand until it erodes into the biliary tree, again resulting in 
hemobilia.The incidence of hemobilia following major liver injury has been reported 
to be as high as 3% in one series 60   but in other reports the overall incidence is 0.18% 
or less 83 .Of 106 cases reviewed by Yoshida et al.56  only one followed penetrating 
injury, but Croce et al. 84 reported that, of 482 patients with accidental liver injury, 
three cases of hemobilia followed blunt trauma and three followed penetrating trauma 
which is comparable to present series with two cases of  hemobilia following blunt 
liver trauma out of 86 cases of accidental liver injury with a overall  incidence of 
2.3% (present series). Stewart et al 85 reported five cases of hemobilia following 
laparoscopic cholecystectomy and four of these were as a result of traumatic 
pseudoaneurysm of right hepatic artery which is comparable to the present series in 
which two cases of post–laparoscopic cholecystectomy right hepatic artery 
pseudoaneurysm have been encountered and treated. There have been 29 cases of 
hemobilia following cholecystectomy reported in the English literature between 
January 1996 and December 1999. Percutaneous trans-catheter angiographic 
embolization (PTAE) was successful in stopping bleeding in 23 cases but failed in 
three. Two patients died from uncontrollable hemobilia53. 
 
FIG-3:AETIOLOGY OF HEMOBILIA – COMPARISON OF CURRENT SERIES WITH 
FOUR REVIEWS OF LITERATURE SINCE 1972 
 
In patients with pancreatitis, the presence of a ruptured arterial 
pseudoaneurysm should be suspected and rapidly investigated whenever there is an 
association of the following criteria: (1) persisting or abrupt increase in abdominal 
pain and (2) decreasing haematocrit and / or hemodynamic instability, and or 
gastrointestinal bleeding with no obvious intraluminal cause. The diagnosis of 
hemobilia requires clinical suspicion in the appropriate clinical situation,that is 
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gastrointestinal bleeding without a demonstrable intestinal source in the presence of 
hepatic trauma or biliary tract surgery53. Investigations are indicated except in cases of 
massive bleeding with hemodynamic instability when immediate surgical arrest of 
bleeding becomes necessary. Upper gastrointestinal endoscopy remains the mainstay 
of diagnosis for those presenting with gastro intestinal bleeding or anemia of chronic 
blood loss 34,53. 
Fig:4 CLINICAL PRESENTATION OF HEMOBILIA – COMPARISON OF CURRENT 
SERIES WITH LITERATURE: (VENN DIAGRAM)  
 
 
 
 
 
Endoscopy is useful as an initial diagnostic investigation in order to detect 
blood oozing from the papilla of vater that clinches the diagnosis of hemosuccus 
pancreaticus 34 particularly in patients presenting with hematemesis resulted from a 
bleeding pseudocyst that communicated with pancreatic duct (hemosuccus 
pancreaticus) as exemplified in case14 of present study. 
 Erosion of a bleeding pseudocyst into the stomach may mimic bleeding gastric 
ulcer 34,86 at endoscopy as exemplified in case1 of present study. A negative upper 
gastrointestinal  endoscopy may result from missed fundal gastric varices, intermittent 
bleeding through the duodenal papilla of vater 34,38 or a bleeding source beyond the 
reach of the gastroscope, as with intestinal varices or rupture of a pseudocyst into the 
small or large intestine. Endoscopy in a suspected case of hemobilia if it shows 
presence of blood or clot at the papilla of vater, hemobilia is likely to be the cause of 
bleeding. However, as few as 12% of these endoscopies may be diagnostic53 and 
further investigations may be required. 
 Color Doppler ultrasound and contrast enhanced helical CT are often 
diagnostic, however, small pseudoaneurysms may be missed and both investigations 
does not offer the benefit of therapeutic interventions 42. 
Abdominal ultrasound was used in all patients in the present study as it offers 
the benefit of greater availability, lower cost, real time capability and no need for 
contrast material. In addition color Doppler scanning enables confirmation of neck of 
the pseudoaneurysm, as Color Doppler flow studies can show whether blood in seen 
flowing into the pseudoaneurysm in systole and out in diastole20. The amount of flow 
can wax and wave, depending on the relative amounts of formed and lysed clot. 
Clotting tends to occur at the periphery, where flow is slower and stasis exists. If the 
entire pseudoaneurysm is filled with clot, no flow is detected on Colour Doppler 
imaging. Acute fresh clot tends to be hyperechoic with older clot becoming more 
hypoechic 20. Ultrasound detects pseudoanermysm because of their pulsatile nature, 
except when perianeurysmal fibrosis or thrombosis of pseudoaneurysm is present 20. A 
pseudoaneurysm may be suggested on ultrasound if a pancreatic mass has a cystic 
component or if a cystic pancreatic mass rapidly enlarges or suddenly changes 
echogenecity or turbulent arterial flow on Doppler imaging. Duplex Doppler 
ultrasound can confirm the diagnosis of   pseudoaneurysm and may identify the vessel 
of origin 20,23. 
Helical CT with intravenous contrast enhancement enables identification of 
parenchymal and vascular abnormalities, such as pseudoaneurysm formation or 
haemorrhage into the pseudocyst or peri pancreatic fluid collection and it indicates the 
necessity for obtaining a subsequent angiography to be targeted. The CT finding of a 
homogeneously enhancing high density structure within or adjacent to a 
pseudocyst/peripancreatic fluid collection or contiguous with a vascular structure 
20,23,32,48 is highly suggestive of clot within a pseudoaneurysm but the presence of a non 
enhancing complex cystic mass near the pancreas does not exclude the diagnosis of 
pseudoaneurysm 20. 
 Selective  angiography  is considered as the gold standard and 
most sensitive method for detecting a pseudoaneurysm20,32,53 . The 
advantages of angiography 32,53 are (1) it detects active bleeding from an 
arterio-biliary fistula, an arterio-portal fistula and pseudoaneurysm (2) it 
detects and localizes a pseudoaneurysm to a specific vessel, and 
demonstrates anatomy thus facilitating the surgical management  and also 
it provides a potential means of temporary or definitive hemostatic 
therapy  via trans-catheter embolization following diagnosis. (3) it is 
attractive because it can demonstrate the erosive vascular changes, it can 
identify vascular disruption and it can precisely define the pathology of 
smaller vessels (4) it confirms the site and etiology of hemobilia with a  
therapeutic intent to arrest the bleeding via embolization. Angiography 
may be negative particularly if the study is performed when there is no 
active bleeding 32. Angiography is usually reserved for those with 
pancreatitis complicated by hemorrhage, occult blood loss, or a pulsatile 
mass suggested or confirmed by CT/Doppler ultrasound and in those with 
active bleeding if hemodynamically stable.ERCP may be useful in the semi 
– elective situation to demonstrate pancreatic duct abnormalities with 
associated pseudocyst in a patient with unexplained overt or occult gastro 
intestinal bleeding that suggests a diagnosis of hemosuccus pancreaticus34 
and should prompt to target angiography as  pseudoaneurysm may be the 
culprit. 
  
TABLE-32 CURRENT SERIES IN COMPARISON WITH PUBLISHED SERIES OF 
VASCULAR COMPLICATIONS IN PANCREATITIS WITH INDIVIDUAL PATIENT DATA 
 
Presentation 
 
Category Author Year Country Recruitme
nt period 
n 
Spont PO PP NB AP C
P 
PS 
Mort 
 
   (%) 
 
Ammori BJ 34 
Rokke O 99  
Carr JA 40   
BalsarkarDJ94  
Koizumi J 95  
Ukrami A 96  
Present Series 
 
1998 
1997 
2000 
2002 
2002 
2002 
2005 
 
UK 
Norway 
US 
India 
Japan 
Japan 
India 
 
1993-1997 
1986-1996 
1988-1998 
 
 
 
1998-2005 
 
5 
3 
16 
1 
1 
1 
11 
 
3 
3 
16 
1 
1 
1 
10 
 
2 
0 
0 
0 
0 
0 
0 
 
0 
0 
0 
0 
0 
0 
1 
 
0 
0 
0 
0 
0 
0 
0 
 
1 
1 
0 
0 
0 
0 
1 
 
0 
0 
0 
0 
1 
0 
3 
 
4 
2 
16 
1 
0 
1 
7 
 
1 (20) 
0 (0) 
3 (19) 
0 (0) 
0 (0) 
0 (0) 
0 (0) 
Spont = Spontaneous hemorrhage in the absence of prior surgery; PO = Post Operative; NB = Not bleeding; AP = Acute 
pancreatitis; CP = Chronic pancreatitis; PS = Pseudocyst; Mort = Mortality; PP = Post procedure (post pancreatic extra corporal 
shock wave lithotripsy) 
 
Non invasive vascular imaging modalites such as Doppler Duplex ultrasound, 
Magnetic Resonance Angiography (MRA) and CT angiography are emergency as a 
promising rapid and non – invasive resolution diagnostic techniques that may offer 
better with dynamic imaging however, they do not allow concurrent therapeutic 
interventions34. All hemodynamically unstable patients are best managed in the 
operating room. However, these are many reports of successful transcatheter 
angiographic embolization even in hemodynamically unstable patients, indicating that 
this may a viable option in selected patients32.  
In several recent reports, PTAE is advocated as the sole therapy for the 
treatment of pancreatitis-associated pseudoaneurysms with high technical success rate 
(75% - 100%) and low morbidity (14% - 25%) and death rates (0% - 14%) 38,42,44 Most 
of these reports, however, are limited by small numbers of patients (3-14 each, 34 
total) and short follow – up period.  
TABLE-33 CURRENT SERIES IN COMPARISON WITH RECENT PUBLISHED SERIES OF 
PATIENTS WITH VASCULAR COMPLICATIONS OF PANCREATITIS: 
 
First Author 
 
Year 
 
Period of publication 
 
n 
 
Aetiology 
 
 
Surg 
first 
 
Angio 
 
Embo 
 
Mort 
(%) 
 
Sand JA 93  
 
Reber PU 97  
 
Rantala A 98  
 
De Perrot M 48   
 
Present Series 
 
 
1997 
 
1999 
 
1996 
 
1999 
 
2005 
 
Institutional cohort 
1991 – 1995 
Institutional cohort 
1994 - 1997  
Institutional cohort 
1979 – 1994 
Institutional cohort 
1978 – 1997 
Institutional cohort 
1998 – 2005 
 
10 
 
5 
 
10 
 
10 
 
11 
 
0 
 
0 
 
0 
 
4 
 
1 
 
0 
 
0 
 
0 
 
0 
 
3 
 
10 
 
5 
 
10 
 
6 
 
7 
 
0 
 
0 
 
8 
 
2 
 
3 
 
10 
 
5 
 
2 
 
8 
 
7 
 
6 
 
5 
 
1 
 
3 
 
5 
 
2 (20) 
 
0 (0) 
 
0 (0) 
 
1 (10) 
 
0 (0) 
Surg first = Surgery as first intervention; Angio = Angiography; Embo = Angiographic embolization successful; Mort = 
Mortality; AP = Acute pancreatitis; CP = Chronic pancreatitis; PS= pseudocyst  
 
 
  
Gambiez et al87 have the longest follow – up on14 patients who were treated 
with PTAE and surgical therapy. Observing no late recurrence of bleeding in a group 
of six patient’s treated with PAE alone after a mean follow-up of 35 months, they 
recommended PTAE as first – line therapy and the reservation of surgery for other 
secondary complications.  
Salam et al 9 reported on 14 true visceral aneurysms and two pancreatitis 
induced pseudoaneurysms that were treated with PTAE with an 81% success rate; 
they advocated PTAE as the primary treatment modality. Huizinga et al 88 documented 
four patients with hemorrhage pseudocysts who were treated with PTAE alone with 
no complications and no death; they suggested that PTAE may obviate the need for 
emergency surgery30-33. 
TABLE- 34 CURRENT SERIES OUTCOME IN COMPARISON WITH RECENT 
PUBLISHED SERIES SHOWING OUTCOMES OF ANGIOGRAPHIC EMBOLIZATION 
FOR PSEUDOANEURYSMAL BLEEDING IN PANCREATITIS: 
 
 
First author Recrui
tment 
period 
(years) 
Disease 
status 
of 
patients 
emboli
zed 
Number 
of 
patients 
in study 
(n) 
Number 
of 
angiogra
ms (n) 
Emboli
zation 
attempt
ed (n) 
 
Successful 
embolizati
on (n) 
Reble
ed (n) 
Survival of 
patients 
embolized 
successfully 
 
Reber 97  
1999 
 
DePerrot48 
1999 
 
Gambiez 87  
1997 
 
Sand 93 
 1997 
 
Present 
Series 
2005 
 
3 
 
 
19 
 
 
11 
 
 
5 
 
 
7 
 
PS 
 
 
CP & 
AP 
 
PS & 
CP 
 
PS 
 
 
AP, 
CP, 
PS 
 
5 
 
 
10 
 
 
14 
 
 
12 
 
 
11 
 
5 
 
 
8 
 
 
14 
 
 
10 
 
 
8 
 
5 
 
 
3 
 
 
14 
 
 
10 
 
 
8 
 
5 (100 %) 
 
 
3 (100 %) 
 
 
11 (79 %) 
 
 
6 (100 %) 
 
 
5 (62.5 %) 
 
0 
 
 
1(33 
%) 
 
0 
 
 
0 
 
 
1 
(12.5 
%) 
 
5 (100 %) 
 
 
2 (66 %) 
 
 
9 (81 %) 
 
 
6 (100 %) 
 
 
5 (100 %) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 34. Mortality and Morbidity rates in literature : 
Author Year Total 
Patients 
Therapy Patie- 
nts 
Morta- 
lity 
Complications 
 
De Perrot[48] 
 
 
Gambiez[88] 
 
 
 
 
 
 
 
 
 
 
Sand[94] 
 
 
 
Marshall[93] 
 
 
 
Present 
Series 
 
 
 
 
1999 
 
 
1997 
 
 
 
 
 
 
 
 
 
 
1997 
 
 
 
1996 
 
 
 
2005 
 
10 
 
 
14 
 
 
 
 
 
 
 
 
 
 
8 
 
 
 
5 
 
 
 
16 
 
Embolization 
Surgery 
 
Embolization 
 
 
 
 
Surgery 
 
 
 
 
 
Embolization 
 
Surgery 
 
Embolization 
 
Surgery 
 
EMBOLI
ZATION 
 
 
 
SURGER
Y 
 
3 
7 
 
14 
 
 
 
 
8 
 
 
 
 
 
6 
 
2 
 
5 
 
4 
 
4 
 
 
 
12 
 
33% (1/3) 
14% (1/7) 
 
7% (1/14) 
 
 
 
 
13% (1/8) 
 
 
 
 
 
0% (0/6) 
 
0% (0/2) 
 
0% (0/5) 
 
0% (0/4) 
 
0% (0/4) 
 
 
 
0% (0/12) 
 
1 recurrent hemorrhage / death 
2 subphrenic abscesses 
 
3 embolization failed to control 
hemorrhage. 
1 duodenal necrosis 
1 arotic thrombosis / death  
 
1 death 
1 subphrenic abscess 
1 septicemia 
 
 
 
1 elevated liver function tests  
1 pseudocyst infection  
None 
 
1 access failure  
1 angiogram failed to show 
bleeding 
 none 
 
1 infection of thrombosed 
pseudoaneurysm 
1 recurrent hemorrhage /survived 
 
2 external pancreatic fistula/ 
survived 
1 Intra abdominal  collection  
1 Pneumonia 
1 Wound sepsis 
Comparison of mortality and complications between embolization and surgery to control hemorrhage 
from pancreatitis- associated pseudoaneurysms in 4 case series in the literature. 
 
Mandel et al 89 treated 19 patients with bleeding peripancreatic arterial 
aneurysms with embolization with a 79% success rate. Gambiez et al 87 treated 14 
patients with bleeding pseudocysts complicating chronic pancreatitis by embolization 
with a success rate of 79%[Table-33]. Angiographic treatment has now been attempted in a 
few patients with arterial pseudoaneurysmal bleeding after pancreatic / biliary surgery  
with a success rate of 63% for pseudoaneurysm after pancreatectomy 69.In the present 
study, the overall embolization rate was 66.6% with 55.5 % clinical  success rate for 
achieving definitive hemostasis which is comparable to the published series87-89.The 
findings of this study, however, do not support PTAE  alone as an adequate sole 
therapy. In the present study, PTAE failed to control hemorrhage in 4 of 9 patients 
that required conversion to operative intervention. Thus PTAE was associated with a 
overall failure rate of 44.4% (4/9) in the present series. This failure rate of 44.4% does 
not support PTAE as an adequate sole primary definitive therapy for hemostasis. 
Furthermore, successful PTAE does not address the possible need for drainage of the 
residual thrombosed pseudoaneurysm. In the present series, 16.6% (1 of 6) patients 
who underwent angiographic embolization, developed a complication related to 
embolization, i:e infection of residual thrombosed pseudoaneurysm which 
subsequently required operative intervention in the form of external drainage of 
retroperitoneal abscess. Out of 6 patients who underwent successful embolization, 
33.3% (two of six) patients (case 6, case 14) had pseudoaneurysm with concomitant 
pseudocyst and underwent PTAE without a drainage procedure. But follow-up CT 
scans showed spontaneous resolution of pseudocyst in all these 2 patients in the 
present series. Another one 16.6% (one of 6) patient (case 8) who had 
pseudoaneurysm with concomitant pseudocyst In this present series required 
ultrasound guided percutaneous catheter drainage (P.C.D) of infected pseudocyst after 
successful PTAE for pseudoaneurysm and the follow up CT at 2 months showed 
complete resolution of pseudocyst. However, Mauro et al 90 reported no further 
treatment is necessary after successful PTAE of a pseudoaneurysm. But in the current 
series, two of 6 (33.3%) patients who belong to the sucessful embolization group, 
ultimately required a pseudocyst / pseudoaneurysm drainage procedure for secondary 
complications such as infection. In addition , the management of thrombosed 
pseudoaneurysm after successful PTAE remains controversial40. Elton et al91 reported 
on three patients who were successfully treated with PTAE and endoscopic drainage 
of the pseudocyst, with short term follow up CT scans (2 and 6 months) in two 
patients demonstrating complete resolution of the pseudocyst. Huizinga.et.al83 
obtained follow up ultrasound scan examinations (at one and two months) in two of 
the four patients who had no surgical drainage, which showed thrombosed pseudocyst 
cavity “to be smaller”, although two of the four also had recurrent pancreatitis. 
Success in six patients after PTAE alone prompted Gambiez et.al 87 to investigate the 
residual cystic cavities documenting that “the volume of pseudocyst decreased in all 
patients”, but no size information was given. 
The mean size of the pseudoaneurysm with secondary complication that 
required operative interventions after PTAE was significantly larger (8cm) than those 
which required angiographic embolotherapy as definitive therapy without secondary 
complications (2.3cm).  
This would imply that the size of pseudoaneurysm is a factor in determining 
the need for surgical intervention (excision or drainage procedure) as standard 
surgical dictum states. We agree with De Perrot et a l48 who view PTAE as a 
temporizing measure and suggest that surgical drainage follow as soon as possible, 
particularly for larger pseudoaneurysms > 10cm. The findings in this series, suggest 
that it is reasonable to proceed with surgical intervention as soon as possible after 
PTAE, particularly when the pseudoaneurysm is large >7cm. In the present study, size 
of the  pseudoaneurysm may not be a predictor of success or failure of trans-catheter 
embolization (mean size 3.8cm versus 6.75cm in present series) which also supported 
by  Tessier et al study 23  on 10 cases of splenic artery pseudoaneurysm, where 
pseudoaneurysm diameter is not a predictor of success or failure of transcatheter 
embolization. 
 Pseudoaneurysm related to pseudocyst formation is often treated by surgery, 
rather than transcatheter embolization, because of the difficulty of embolizing large 
pseudocyst cavities 40. In the present series, a substantial number of patients 72.7% 
have associated pseudocyst. From this group of patients, most 75% have undergone 
surgical intervention with no reported failure. In contrast, embolization failed in a 
substantial number of patients 50% with associated pseudocyst compared with no 
reported failure in patients without pseudocyst in the present series. This indicates that 
pseudoaneurysm associated with pseudocyst most often requires surgical intervention 
rather than angiographic embolization. But in patients with associated pseudocyst, 
transcatheter embolization may be appropriate for pseudoaneurysm that ruptures 
within the pseudocyst, to improve hemodynamic status, enabling less urgent surgical 
intervention39,40 . If transcatheter embolization is chosen as therapeutic modality, most 
authors recommend embolization of only the inflow and outflow feeding vessels, 
which will result in thrombosis of pseudoaneurysm. For this procedure, the artery 
from which the pseudoaneurysm originates is selectively catheterized and embolized 
with coils. This effectively excludes the pseudoaneurysm from the circulation and 
enables thrombosis. In addition, because the pseudoaneurysm wall is thin, this method 
aviods the possible pseudoaneurysm rupture by the embolization resulted from 
inablity to selectively catherize the vessel because of arterial vasospasm, rupture of 
the pseudoaneurysm during embolization or arterial perforation by the catheter 39,40 . 
The complications after catheter embolization include pseudoaneurysm rupture, 
traumatic dissection, inadvertent   embolization of adjacent non bleeding vessels; 
pain, pancreatic abscess, splenic infarction, splenic abscess (splenic artery 
embolization); Duodenal necrosis,ischaemic duodenal perforation (Gastroduodenal 
artery embolization); fatal hepatic necrosis (Hepatic artery embolization); and 
infection of residual thrombosed pseudoaneurysm which was encountered in one of 
our patient (case 15) but all these complications are rare39. 
Pseudoaneurysm   size is not a determinant of rupture, both the smallest (2cm) 
and largest (10cm) pseudoaneurysm reported in the present series were ruptured at 
presentation. In addition, only 2.5% of reported pseudoaneurysms are asymptomatic23. 
In the present series, all patients 100% had symptoms, with the average 
pseudoaneurysm size of 5.1 cm. (Range 2 – 10cm). Finally, because the natural 
history of asymptomatic pseudoaneurysms are not known, it is better to treat all 
pseudoaneurysms, regardless of size or symptoms23. 
In the present series, surgical  interventions  75% (n= 12/16) has no reported 
failure (no recurrent hemorrhage, no recurrence of pseudoaneurysm). Arterial ligation  
alone for splenic artery pseudoaneurysm has a high failure rate of 43% in Tessier et al 
study23. Some authors achieve good results with arterial ligation and recommend this 
approach for lesions situated in head and body of the pancreas and for those easily 
accessible34. However, several authors report high rebleeding rates of upto 80%34. In 
our series no rebleeding occurred in two patients treated with trans-cystic suture 
ligation. The overall surgical morbidity rate was 41.6% (4/12) which is comparable to 
the reported complication rate of 0-29 %  and 87% in the setting of necrotizing 
pancreatitis in the literature34. There were no post operative deaths in the present 
series but the reported peri operative mortality rate in the literature was 12 – 37% 34 
after surgery. Surgical approach to bleeding pseudoaneurysm is often hazardous or 
even unsuccessful owing to anatomical inaccessibility of bleeding vessels and in 
addition surgery is technically difficult because the tissues are hyperaemic, 
edematous, friable and the tissue planes are difficult to dissect owing to dense 
inflammatory adhesions69.  
There is still a debate about the best type of surgical procedure for bleeding 
pancreatic pseudoaneurysms, the two possibilities are resection of the affected 
pancreatic segment or extracystic / intracystic arterial ligation with external / internal 
drainage of coexisting pseudocysts18,33.  The choice between ligation and pancreatic 
resection remains controversial, but is largely governed by site and accessibility of the 
bleeding vessel, associated pathology, previous internal drainage, patient condition, 
surgical experience, and a balance between risk of rebleeding and procedure 
mortality. Even though endoaneurysmorrhaphy seems more  simple to perform, we 
would not recommend this method because of high rebleeding rates observed in 
several series75. This may be explained by the friability of the peripancreatic tissues 
and the possible persistance of the enzymatic digestion phenomenon even after 
pseudocyst drainage 75and weakness of arterial sutures in these tissues.  
Some authors recommend extracystic ligation of the bleeding artery when it is 
accessible 34. On the other hand, when a radical surgical procedure is performed, in 
addition to the intraoperative difficulties, the main drawback of pancreatic resection is 
the risk of post-operative sepsis/ anastomotic leakage, especially when treating 
bleeding lesions in the head of the pancreas.Therefore, the present study recommends, 
intracystic arterial ligation and external drainage for bleeding lesions in the head of 
pancreas; distal pancreatectomy with splenectomy for bleeding lesions in the tail / 
body of pancreas. External pancreatic fistula is the major postoperative complications 
occurred in 16.6% (present series) of patients  which most often heals spontaneously 
with conservative management. 
Long term results after PTAE for pancreatitis related pseudoaneurysm are 
scarce in the literature. Several authors have do documented recurrent hemorrhage 
after initial successful PTAE 32,40,79. The incidence of recanalization requiring repeat 
PTAE for visceral aneurysms and pseudoaneurysms was reported to be 12% and 37% 
in two studies 32,79. 
 In the present series, follow up CT scans revealed no recurrent bleeding or no 
recurrence of pseudoaneurysm formation after PTAE in 5 patients, with resolution of 
pseudocyst documented in all 2 patients who underwent successful embolization in 
the pseudocyst group. 
SUMMARY : 
The limitations of this study are the small number of patients and the inherent 
deficiencies of retrospective study single institution observational cohort study. The 
development of a pancreatitis induced pseudoaneurysm and post – traumatic 
pseudoaneurysm following pancreatic / biliary surgery and blunt liver trauma are 
unusual vascular complications. Thus, it is difficult for a single institution to gather a 
large experience in the management of this uncommon   problem.  
The most common cause of visceral artery pseudoaneurysm in our study is 
pancreatic inflammatory disease; however operative / accidental trauma is also a 
common cause. The peak age incidence for pancreatitis – related pseudoaneurysm is 
third to fifth decade of life with an alcoholic male preponderance.  
The most common pancreatic disease associated   with pseudoaneurysm is the 
alcoholic chronic pancreatitis in the present study. The most frequent type of clinical 
presentation of pancreatitis – related and trauma – related pseudoaneurysm was 
gastrointestinal bleeding in the present study. Pseudocysts were the commonest mode 
of clinical presentation of pancreatitis – related major vascular complications. 
Majority of patients presenting with pseudoaneurysmal bleed required aggressive 
recusitation with crystalloids and blood transfusion both in hemosuccus pancreaticus 
and hemobilia groups.  Upper gastro intestinal endoscopy and helical CT scan are the 
initial diagnostic investigations of choice as it allows subsequent angiography to be 
targeted in hemodynamically stable patients with suspected pseudoaneurysmal bleed. 
The gold standard and most sensitive method for diagnosing bleeding visceral 
artery pseudoaneurysms is the conventional angiography as it confirms the site and 
etiology and also it provides the best method of initial treatment.  Angiography should 
be reserved for those patients shown to have pancreatitis, pancreatic / biliary surgery, 
liver trauma complicated by hemorrhage, occult blood loss or a pulsatile mass.  
Most common bleeding vessel implicated in pseudoaneurysmal bleed is the 
splenic artery followed by hepatic artery in the present study. All patients with 
pseudoaneurysm are symptomatic in the present study with an average size of 
pseudoaneurysm of 5.1cm but only 2.5% are asymptomatic as reported in literature. 
Pseudoaneurysm size may not be a predictor of the success or failure of transcatheter 
embolization as there was significant difference in the average pseudoaneurysm 
diameter in patients in whom embolization was failed and those in whom 
embolization was successful. Pseudoaneurysm size is not a determinant of rupture as 
both smallest and largest size of  pseudoaneurysms were ruptured at presentation.   
Since natural history of asymptomatic visceral artery pseudoaneurysms are not 
known from our experience and the literature evidence, we recommend repair of all 
pseudoaneurysms, regardless of size or symptoms. Pseudoaneurysm with concomitant 
pseudocyst is often treated with surgical intervention rather than transcatheter 
embolization as it is associated with high failure rate of 50% in the present study. 
Transcatheter embolization carries a significant failure rate of 75% in the present 
study when used for treatment of splenic artery pseudoaneurysms, especially when 
there is associated pseudocyst. Transcatheter angiographic embolization may be ideal 
for pseudoaneurysm of pancreaticoduodenal arcade as it is associated with high 
success rate with coils as the embolic agent of choice in the present study.  
Angiographic embolization cannot be considered as an adequate sole therapy 
for pseudoaneurysmal bleed as it is associated with a overall failure rate of 45% in the 
present series. Angiographic embolization should be considered as first line therapy in 
all patients presenting with either sentinel or massive pseudoaneurysmal bleed after 
adequate resuscitation, as it can achieve temporary hemostatis in 16.6 % of cases and 
also permanent hemostasis in 83.3% of cases among the embolization group (n=6) in 
the present study. Surgery should be reserved as the second line therapy except in the 
setting of actively bleeding lesions with torrential hemorrhage. 
The appropriate surgical procedure to treat bleeding lesion in head of pancreas 
would be intracystic ligation with external drainage and for bleeding lesion in the tail 
of pancreas is distal pancreatectomy as it has proved durable, save and effective and 
offers the best chance of cure with no failure to control bleed as exemplified in the 
present study.  
 
 
  
 
 
 
CONCLUSION:   
 
A high index of suspicion is essential for early prompt diagnosis of  
pseudoaneurysmal bleed with expeditious investigations and timed therapy in all 
patients presenting with obscure / overt gastrointestinal / intra abdominal bleeding 
particularly in the background of pancreatitis and liver trauma and in the 
postoperative setting of pancreatic / biliary surgery in order to reduce the morbidity 
and mortality. Non invasive imaging such as Colour Doppler Ultrasound, multislice 
Helical CT and CT angiography are useful in establishing, the early diagnosis of 
pseudoaneurysm. Surgery and PTAE play complementary management roles. 
Selective/Super-selective angiographic trans-catheter coil embolization should be 
considered as the first line treatment of choice in all patients presenting with sentinel 
or massive pseudoaneurysmal bleeding after adequate resuscitation because,(1)it is a 
safe ,minimally invasive and effective alternative therapy to surgery (2) it can achieve 
temporary hemostasis and sometimes even permanent hemostasis,  (3) it allows 
hemodynamic stabilization and prevents the need for an urgent high risk 
surgery(converting a high risk emergency surgery with its attended high morbidity / 
mortality into an elective surgery with a more favourable outcome),  (4) it has an 
impressive therapeutic success rate coupled with a negligible morbidity and mortality, 
(4) it is also prudent to regard angiographic embolization as“buying time” for careful 
disease re-evaluation in order to avoid inappropriate surgery in an emergency 
situation. Surgery should be reserved only for (i) actively bleeding lesions unsuitable 
for angioembolization with significant haemodynamic instability caused by and 
exsanguinating / torrential haemorrhage that obviates the need for angiography(ii) 
Unsuccessful / failed / non availability of therapeutic angiographic embolization. (iii) 
secondary complications such as extrinsic compression or sepsis.  
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1 40 M 2days 2days 1mon 2 yrs  ---  +  +  -  -  +  --  --  -- 10.2 5.9 10,600 17 26 22 102 N  --  --
2 42 M 2days 3days 6mon 5 yrs  ---  --  --  +  +  +  --  --  -- 10.8 6.2 10800 18 24 23 112 N  --  --
3 40 F 2days 3days  -- 10 days  ---  +  +  -  -  +  --  --  -- 9.6 4.6 11000 26 22 20 126 N  --  --
4 32 F 2days 3days  --- 3 monm  +  +  +  -  -  +  +  --  -- 11.4 8.4 9800 81 42 42 480 N  +  --
5 47 M 3days 3days 10days 2 yrs  ---  --  --  -  -  +  --  --  -- 11.2 7.2 9600 17 24 30 136 N  --  --
6 31 M  --  -- 3mon 2.5 yrs  ---  +  +  -  -  -  --  --  -- 11.6 8.2 9400 18 26 28 112 N  --  --
7 36 F 3days 3days  --- 2 mon  ---  +  +  -  -  -  --  --  -- 12.6 8.2 10200 38 30 30 114 N  --  --
8 43 M  --  -- 3mon 2 yrs 0  +  +  -  -  -  --  --  -- 13.3 8 15000 65 20 58 306 N  +  +
9 39 M  --  -- 2mon 3 yrs  ---  +  +  -  -  -  --  --  -- 12.4 7.8 12600 15 30 26 142 N  --  --
10 18 M 5days 2days 2mon 3 yrs  ---  +  +  -  -  +  --  --  -- 12.8 7.4 11400 17 35 24 138 N  --  --
11 39 M 2days 4days 3mon 3 yrs  ---  +  +  -  -  -  --  --  -- 11.4 7 12000 16 32 20 86 N  --  --
12 12 F 2days 3days 2mon 4 yrs  ---  +  +  -  -  -  --  --  -- 12 8.4 10400 17 33 22 116 N  --  --
13 37 M 2days 3days  --- 1.5 mon  ---  +  +  -  -  +  --  --  -- 10.4 7.4 11600 42 42 26 118 N  --  --
14 53 M 2days 5days 3mon 4 yrs  ---  +  +  -  -  -  --  --  -- 13.2 7.9 9800 17 35 24 120 N  --  +
15 51 M  --  -- 1mon 2 yrs  ---  --  +  -  -  -  --  --  -- 10.8 7.6 13600 16 34 22 96 N  --  --
16 53 M  -- 2days  -- 15 days  ---  --  ---  -  -  +  + 62 day203 days 9.8 8.2 5800 22 24 20 86 N  --  --
Blood Investigations
MASTER CHART - I
Clinical Presentation
Male  
na
He 
mop
H.che  
zia
Ane 
mia
feve
r  
SB 
via 
MB  via 
abd. 
Vomit- Vomitting in duration, Abd.pain - Abdominal pain, H.em – Hematemesis, Hemop – Hemoptysis, H.chezia – Hematochezia, SB  - Sentinel Bleed, MB - Major Bleed, HB - Hemoglobin g/dl, TC - 
Total White Cell Count cells / cmm 3,  S.Bili - Serum Bilirubin μmol/l, S.AST  - Aspartate aminotransferase (IU/L), S.ALT - Alanine aminotransferase (IU/L), SAP - Serum Alkaline Phosphatase (IU), PT - 
Prothombin time (secs), B.Obs. - Biliary Obstruction, GOO - Gastric Outlet Obstruction
Pat 
ient Age
Gen  
der Nausea vomit back pain abd. pain Jaun  dice H.em. Hb 1 Hb 2 TC S.Bili S.AST GOO
S.AL
T SAP PT B Obs.























